COMS

Calendar of upcoming scientific conferences

Home | Conference Management System | Conference Listings | Advertise | Contact | About
German French English
You are in: HomeConference ListingsHealthcare/Medicine → Pharmacology and Drug Development
Cancer Vaccines
COPD
Advances in Cell Based Assays
Cuescience – Live-Streaming war noch nie so einfach.

Conference Management Software

Our Conference Management Software (COMS) can be used for online:

  • registration
  • payment
  • paper submission
  • review process
  • paper selection
  • production of the book of abstracts

Read more ...
Try our demo online

Conferences and Meetings on Pharmacology and Drug Development

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

ALL COUNTRIES

1.2nd World Congress on NeuroTherapeutics (DDDN) Dilemmas, Debates, Discussion
 Dates 03 Sep 2015 → 06 Sep 2015
[ID=667374] Go to top of page
 LocationPrague, Czech Republic
 Abstract DDDN is a concept congress dealing mainly with therapeutic issues of neurological diseases. Despite the false perception that neurology deals with untreatable conditions, neurological practice is constantly undergoing dramatic changes, and numerous drugs and other forms of therapy continue to emerge. Their integration into common practice is associated with controversies and dilemmas which will be spotlighted at this congress. Likewise, innovations and future trends in therapy will be presented.
 Weblink http://www.congressmed.com/neurology/
 Related subject(s) Neurology
  
2.Pharma — 4th Annual Pharma Anti-Counterfeiting 2015
 Dates 08 Sep 2015 → 09 Sep 2015
[ID=731549] Go to top of page
 LocationLondon, United Kingdom
 Abstract Greetings from Virtue Insight, I am happy to invite you and your colleagues to be a sponsor / delegate for our upcoming conference “4th Annual Pharma Anti-Counterfeiting 2015” the confer be held on 8th & 9th September 2015 at The Kensington Close Hotel, Wrights Lane, London, UK. Key Speakers: • Geoffroy Bessaud, AVP, Anti-counterfeiting Coordination, Sanofi • Ravi Kalyanaraman, Associate Director, Bristol-Myers Squibb (USA) • Lynda Scammell Senior Policy Manager, Relationship Manager,Enforcement Group MHRA • Wendy Greenall, Head of Anti-Counterfeiting Laboratory for Europe, Middle East &Africa Pfizer • Conor Dufrain, Assistant Attaché, Homeland Security Investigations(HSI) London • Dr. Ulrike Kreysa, Vice-President Healthcare, GS1 Global Office • Mike Isles, Executive Director, European Alliance for Access to Safe Medicines (EAASM) • Benoit Goyens, IPM Private Sector – Manager, World Customs Organization • Sultan Dajani,Community Pharamacist,Royal Pharmaceutical Society • Pipasha Biswas,Director,Symogen • Mark Davison, CEO, Blue Sphere Health • Nigel Banfield, Sales Manager Pharmaceuticals UK,OCS Checkweighers • Stephen Wilkins, Secretary General, Child-Safe Packaging Group • Franklin Apfel,Managing Director,World Health Communication Associates • Jose Henrique Vasi Werner,Partner,Dannemann Siemsen • Gillian Lennard, Director of Regulatory Affairs, European Regulatory • Phil Lewis, International Cooperation & Legal Affairs Department, Cooperation Programmes Service,Office for Harmonization in the Internal MARKET (OHIM) Plus Many More... Target Audience-Industry:- Pharmaceutical manufacturers and distributors, Healthcare professionals, Pharmacists, Brand – protection, enforcement, security, integrity and management companies, Drug regulatory agencies, customs and police, Intergovernmental organizations (IGOs) involved in healthcare and IPR protection, Non-governmental organizations (NGOs) active in healthcare, Patients’ representatives, Healthcare research organizations, Pharmaceutical associations, Anti-counterfeiting organizations, Packaging, labeling and converting companies, Authentication technology suppliers, Anti-counterfeiting service suppliers – IP specialists, investigators, lawyers. Conference Booking Details:- Introductory Offer (3 delegate places for the price of 2):- A huge saving of £ 800 - (Limited seats left) Early Discount (13th July 2015 - 8th August 2015): Conference Delegate Pass (£ 800 + VAT per delegate) Standard Registration (9th August 2015):- Conference Delegate Pass (£ 1100 + VAT per delegate) We also have sponsorship opportunities available for the event which gives you an opportunity to speak/exhibit and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts. Conference Sponsor & Exhibition Stall – Should you wish to Sponsor, or purchase a Exhibition Stall (Booth) or a paid Speaker Slot, you can simply email your interest to us To register or for more details please contact :- Swetha:- +44 2036120886, Email - swetha@virtueinsight.co.in Should you or any of your colleagues be interested in participating, please let me know and I would be glad assist you accordingly. Should you have any questions about this conference please feel free to let me know anytime and I would be happy to provide you with any info that you may require Thank you for your time and consideration. I look forward to hearing from you. Thanks, Swetha
 Topics Pharmaceutical manufacturers and distributors, Healthcare professionals, Pharmacists, Brand – protection, enforcement, security, integrity and management companies, Drug regulatory agencies, customs and police
 Weblink http://www.virtueinsight.com/pharma/4th-Annual-Pharma-Anti-Counterfeiting-2015/
 Contact Swetha; Phone: [9940043915]; Email: swetha@virtueinsight.co.in
  
3.6th Non-Coding RNA and RNAi therapeutics
 Dates 09 Sep 2015 → 10 Sep 2015
[ID=720007] Go to top of page
 LocationPhiladelphia, United States
 Abstract We invite you to attend the  6th Non-Coding RNA & RNAi Therapeutics Conference, which will take place  September 9-10, 2015  in  Philadelphia, PA. The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues in the RNA research field. Emerging areas in RNA research provide great insight into promising therapeutic tools. Delivery has remained a solid focus for understanding how RNA has proven to play a vital and central role in all cellular function. The excitement and interest that CRISPR brings continues to progress the evolution of genome editing tools. We will also dive into application of aptamers in diagnostic and therapeutic settings. 
 Weblink http://www.gtcbio.com/conferences/non-coding-rna-rnai-therapeutics-overview
  
4.2015 Pharma CI USA Conference & Exhibition
 Dates 10 Sep 2015 → 11 Sep 2015
[ID=710206] Go to top of page
 LocationParsippany, United States
 Abstract The Pharma CI Conference & Exhibition (September 10-11, 2015, www.pharmaciconference.com ) is THE INDUSTRY'S GOLD STANDARD for senior level pharmaceutical, biotechnology, medical device, and diagnostics professionals seeking the latest news and the rare chance to network with all the industry's luminaries. This is the biggest and best gathering of pharmaceutical competitive intelligence thought leaders (75+ speakers)! Join us at this premier gathering and network with other key decision makers as you learn about the most pressing and relevant issues facing the industry today. Enjoy the highest ratio of industry practitioners (pharma, biotech, medical device and diagnostics) of any pharma intelligence conference!
 Topics -Pharma CI Conference & Exhibition -senior level pharmaceutical, biotechnology, medical device, and diagnostics professionals seeking the latest news and the rare chance to network with all the industry's luminaries
 Weblink http://www.pharmaciconference.com/
 Contact Phone: [212 228 7974]; Email: support@pharmaciconference.com
  
5.6th BBBB Conference on Pharmaceutical Sciences
 Dates 10 Sep 2015 → 12 Sep 2015
[ID=702114] Go to top of page
 LocationHelsinki, Finland
 Weblink http://www.cvent.com/d/f4q4pj
  
6.Business Principles for Medical Science Liaisons - with Edouard Demeire
 Dates 14 Sep 2015 → 15 Sep 2015
[ID=716486] Go to top of page
 LocationZurich, Switzerland
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-medical-science-liaisons-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
7.General and Advanced Receptor Theory workshop
 Start date15 Sep 2015
[ID=707914] Go to top of page
 LocationGraz, Austria
 Abstract This workshop will develop and refresh knowledge of how common theories of drug action can be quantified and how simple receptor mechanisms can be used to interpret pharmacological data.
 Weblink http://www.bps.ac.uk/meetings/GART2015
  
8.WMTF 2015 — World Medtech Forum Lucerne
 Dates 15 Sep 2015 → 17 Sep 2015
[ID=647534] Go to top of page
 LocationLuzern, Switzerland
 Abstract The World Medtech Forum is a high-caliber platform for the international medtech sector – made by the industry for the industry and Made in Switzerland! This platform is set to be an integral part of the medtech scene and is open to you as an exhibitor, visitor or congress attendee.
 Weblink http://www.medtech-forum.ch/en/medtech_messe/_startseite.htm
 Related subject(s) Medicine (in general); Exhibitions and Trade Shows in Chemistry, Laboratory Technology
  
9.BPA2015 — BioPharm America™ 2015
 Dates 15 Sep 2015 → 17 Sep 2015
[ID=729783] Go to top of page
 LocationBoston, MA, United States
 Abstract BioPharm America™ is where biotech industry partnerships get started. This three-day conference provides a proven and highly productive format for establishing new business relationships. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. In 2014, BioPharm America attracted 850+ delegates from over 500 companies who participated in 2350+ scheduled one-to-one meetings.
 Topics partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance
 Weblink http://www.ebdgroup.com/bpa
 Contact Elaine Bundy; Phone: [+1 760 692 5919]; Email: ebundy@ebdgroup.com
 Related subject(s) Biotechnology
  
10.GPCRs: Beyond structure towards therapy
 Dates 16 Sep 2015 → 18 Sep 2015
[ID=685656] Go to top of page
 LocationMonash University Conference Centre, Prato, Italy
 Abstract Biochemical Society Focused meeting in collaboration with Monash Institute of Pharmaceutical Sciences.

GPCRs are the largest protein family in the human genome and the largest therapeutic target, so are of great interest to both basic scientists and the pharmaceutical industry. Recent advances in the field have utilised atomic-level structural information as a 'springboard' to go beyond simply looking at crystal structures, to exploit new insights into the functional dynamics of GPCRs and to apply this knowledge to drug discovery and therapeutics.

 Weblink http://www.biochemistry.org/Conferences/AllConferences/tabid/379/View/Conference/MeetingNo/SA173/Default.aspx
 Related subject(s) Molecular Biology
  
11.EFMC Young Medicinal Chemist Symposium
 Start date17 Sep 2015
[ID=686557] Go to top of page
 LocationAntwerp, Belgium
 Abstract The EFMC Young Medicinal Chemist Symposium is an initiative of the European Federation for Medicinal Chemistry (EFMC). This one-Day Symposium, organised in connection with Frontiers in Medicinal Chemistry 2015.
 Weblink http://www.efmc-ymcs.org
 Related subject(s) Summer/Winter Schools and Events for Chemistry Students; Biochemistry and Medicinal Chemistry, Toxicology
  
12.GLC — 3rd Annual Pharmacovigilance Forum
 Dates 17 Sep 2015 → 18 Sep 2015
[ID=718049] Go to top of page
 LocationVienna, Austria
 Abstract The 2nd Annual Pharmacovigilance Forum continues to investigate the impact of the evolving regulation both on the national and international level. It reveals such strategies and best practices that can be adopted in order to overcome such problems as risk mitigation, data collection and management, monitoring adverse drug reactions and challenges in the field of QPPV. Furthermore, the event provides updates on the assessment of PRAC, PSUR principles and the newly launched Black Triangle Symbol legislation.The Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry.
 Topics Regulatory overview of the past year and forecast for 2015, Essential updates on the current situation of PRAC, Understanding regulatory requirements for the Pharmacovigilance System Master File (PSMF), Solutions to Improve and maintain Pharmacovigilance System Master File (PSMF) in practice, Principles of the Risk Management Plan and best practice in risk mitigation, Advantages and disadvantages of outsourcing in the pharmaceutical industry, Emerging IT Solutions to enhance Pharmacovigilance System, Investigate what is required for a Post-Authorisation, Safety Studies (PASS) and Post- Authorisation Efficacy Studies (PAES), Pitfalls of ADR data collection and management, Adaption of real World Evidence in Pharmacovigilance and Drug Safety, Challenges of the recently launched Black Triangle Symbol, General principles of writing and submitting Periodic Safety Update Reports (PSUR), Strategies to overcome the challenges of Qualified Person for Pharmacovigilance (QPPV), Investigate the impact of the new EU requirement on QPPV role, Key issue: communication with the patients, Path of challenges towards the optimal signal detection Importance of monitoring in the industry
 Weblink http://www.globalleadingconferences.com/conferences/pharmacovigilance
 Contact Ana Brown; Phone: [+3618480723]; Email: marketing@glceurope.com
 Related subject(s) Regulation in Medicine and Pharmacology
  
13.Quality by Design
 Dates 21 Sep 2015 → 23 Sep 2015
[ID=725749] Go to top of page
 LocationVienna, Austria
 Abstract Making next generation process efficiency a reality for Chemical and Biotech Product Development and Optimisation. Quality by Design (QbD) concepts are becoming the defacto best practice spearheaded by the FDA and EMA. But how can you implement ICH Q8-Q11 with confidence for small molecules and biotech products? As part of our Chemical Manufacturing series, DIA brings together expert faculty from Regulatory agencies, academia and industry. ICH and DoE expertise will accompany you to building a practical knowledge base.
 Weblink http://atnd.it/27342-0
  
14.Biosimilars Global Congress 2015 Europe
 Dates 21 Sep 2015 → 23 Sep 2015
[ID=728087] Go to top of page
 LocationLondon, United Kingdom
 Abstract Over the last decade, there has been a swift increase in the quantity of biological medicines that have received regulatory approval globally. To obtain approval for consumption, a biosimilar medicine which is medicine that is develop to be similar to an existing biological medicine, have to establish that they are as safe and effective as the original reference medicine and have the same quality. A number of top-selling biological medicines have lost or will be losing their patent over the next few years, particularly, monoclonal antibodies. Hence, Biosimilar Medicines are develop in expectation of imminent patent expiry of innovator biologics drugs. Although biosimilars are already in use to some extent, it is likely that their availability and use will become more comprehensive over the next few years as it has the potential to present a more cost effective tool for pharmaceutical expenditures. The Congress will provide a unique platform for knowledge sharing and convergence from Pharmaceuticals, Biotechnology, Regulatory and many more. The congress will also cover a diverse range of topics and offer an interesting insight as to latest strategies and obstacles faced by the industry, from the development to market of Biosimilars.
 Weblink http://www.paradigmglobalevents.com/events/biosimilars-global-congress-2015-europe/
  
15.DOT — Discovery on Target
 Dates 21 Sep 2015 → 24 Sep 2015
[ID=729246] Go to top of page
 LocationBoston, United States
 Abstract Cambridge Healthtech Institute will host its 13th Annual Discovery on Target event showcasing current and emerging “hot” targets for the pharmaceutical industry September 21-24, 2015 in Boston, MA. Spanning five days, the event attracts 1,000+ attendees (from 21 countries), composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations. In 2015 the event is comprised of 15 conference tracks, 3 Symposia, 15 short courses, 35+ interactive breakout discussion groups, an exhibit hall of 65 companies, and dedicated poster viewing and networking sessions. The 13th Annual Discovery on Target event assembles an impressive group of 200+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.
 Weblink http://www.discoveryontarget.com/
 Contact Phone: [7819745400]; Email: chi@healthtech.com
 Related subject(s) Clinical trials
  
16.The Pharma Business Development Course - with Martin Austin
 Dates 22 Sep 2015 → 23 Sep 2015
[ID=716639] Go to top of page
 LocationZurich, Switzerland
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-business-development-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
17.EYE — Targeting Ocular Disorders
 Dates 22 Sep 2015 → 23 Sep 2015
[ID=729267] Go to top of page
 LocationBoston, United States
 Abstract Ophthalmological pharmacology has historically lacked systematic understanding of disease mechanisms, especially of those for the back of the eye. This is now changing with the discovery of novel targets and pathways paired with a greater understanding of the role of genetics in ocular pathologies.The third annual Targeting Ocular Disorders will cover some of the most promising emerging therapies in the treatment of ocular diseases. Special focus with be given to age-related macular degeneration and retinopathy. Designated sessions will emphasize the role of precise imaging techniques and animal models in accelerating preclinical development. Recent solutions in drug delivery to the back of the eye will also be discussed.
 Weblink http://www.healthtech.com/targeting-ocular-disorders/
 Contact Phone: [7819745400]; Email: chi@healthtech.com
 Related subject(s) Ophthalmology
  
18.Big DiP USA 2015 — Big Data in Pharma USA
 Dates 22 Sep 2015 → 24 Sep 2015
[ID=726417] Go to top of page
 LocationBoston, United States
 Abstract Big DiP USA is back for the 3rd year running and the 2015 meeting will accelerate the development of your therapies and inform your commercial decision making through enhanced data interpretation.
 Topics Big Data, Pharma,
 Weblink http://big-datapharma.com/
 Contact Charlotte Parnaby; Phone: [+1 212 537 5898]; Email: info@hansonwade.com
  
19.Principles of Patient Adherence - with Prof. John Weinman and Jeremy Sayers
 Start date23 Sep 2015
[ID=695037] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-patient-adherence-seminar.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
20.13th Annual Pharmaceutical IT Congress — 13th Annual Pharmaceutical IT Congress
 Dates 23 Sep 2015 → 24 Sep 2015
[ID=708406] Go to top of page
 LocationLondon, United Kingdom
 Topics Big Data, Translational Informatics, Data Management, IT Solutions
 Weblink http://www.pharmatechnology-summit.com/download-agenda-marketing/
  
21.PharmaNMR — Application of NMR Spectroscopy in Pharmaceutical Industry
 Dates 23 Sep 2015 → 25 Sep 2015
[ID=727081] Go to top of page
 LocationRovinj, St. Andrew Island, Croatia
 Abstract The main goal of the PharmaNMR conference is to promote dissemination of the latest achievements in using NMR techniques in drug design and development. Participation at the conference is free of charge.
 Topics NMR, Phamaceutical Industry, Drug Development LC-SPE-NMR, LC-SPE-NMR-MS
 Weblink http://met4pharm-conference.com/
 Contact Nikola Bregovi; Email: nbregovic@chem.pmf.hr
 Related subject(s) Mass Spectroscopy and NMR
  
22.Health Economics for Non-Health-Economists - with Prof. Dr. Lieven Annemans
 Dates 24 Sep 2015 → 25 Sep 2015
[ID=716569] Go to top of page
 LocationZurich, Switzerland
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-health-economics-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
23.Pharmacovigilance Inspections and Audit Masterclass
 Dates 24 Sep 2015 → 25 Sep 2015
[ID=711590] Go to top of page
 LocationFrankfurt, Germany
 Abstract This course will give a clear understanding of what to expect of inspections as well as how to ensure full compliance with regulatory requirements. Directive 2010/84/EU legislation has navigated post-marketing drug safety towards higher standards, meaning lack of compliance will not only impact a company‘s public image but result in hefty fines. Therefore, closer communication with regulators is crucial not only for minimum compliance but for further enhancement of patient safety standards.
 Topics Pharmacovigilance, Inspections, Audits, PSMF, Drug Safety, Signal Detection, Data Mining, Benefit/Risk Assessment, QPPV, Medical Affairs, Medical Information, Regulatory Affairs, R&D, Clinical Safety, Pharmacology, Pharmacoepidemiology, Risk Management, PV Quality Assurance
 Weblink http://pharma.flemingeurope.com/pharmacovigilance-inspections-audit-masterclass?utm_source=listing_conference-service&utm_medium=listing&utm_campaign=BATD129_home
 Contact Andrea Weber; Phone: [+421 257 272 155]; Email: andrea.weber@flemingeurope.com
 Related subject(s) Regulation in Medicine and Pharmacology
  
24.TB & HIV Vaccine Development 2015
 Dates 24 Sep 2015 → 27 Sep 2015
[ID=646434] Go to top of page
 LocationToledo, Spain
 Weblink http://www.zingconferences.com/conferences/tb-vaccine-development/
  
25.SPS AM15 — Safety Pharmacology Society 15th Annual Meeting
 Dates 28 Sep 2015 → 01 Oct 2015
[ID=694674] Go to top of page
 LocationPrague, Czech Republic
 Abstract The 2015 Scientific Program will feature a diverse range of scientific sessions organized into two theme tracks and covering issues specific to important therapeutic areas, new regulatory developments and new technologies so that attendees can stay abreast of new content and developments in all areas of safety pharmacology. The meeting will also offer a broad Continuing Education program both on an introductory level as well as advanced courses for the expert.
 Topics Central Nervous System, Translational, Cardiovascular, ECG, CiPA, CIPA, Integrative Pharmacology, Sensory Systems, Abuse Liability, Novel In Vitro Models, NC3Rs, In Silico, Regulatory, stem cells, preclinical, biomarkers, discovery models,
 Weblink http://www.safetypharmacology.org/am2015/
 Contact Krystle Correll; Phone: [7034387508]; Email: kcorrell@safetypharmacology.org
 Related subject(s) Regulation in Medicine and Pharmacology
  
26.Principles of Pharma Market Access in Europe - with Lloyd Morgan and Mark Silvey
 Dates 29 Sep 2015 → 30 Sep 2015
[ID=716488] Go to top of page
 LocationLondon, United Kingdom
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-market-access-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
27.BHR — Bio Pharma HR
 Dates 29 Sep 2015 → 30 Sep 2015
[ID=725222] Go to top of page
 LocationBoston, United States
 Abstract BioPharma HR is the definitive meeting place for progressive Life Sciences HR leaders to challenge traditional thinking and engage in a disruptive conversation about the future of HR in our industry.
 Topics Life Sciences, HR, Bio Pharma
 Weblink http://biopharma-hr.com/
 Contact Charlotte Parnaby; Phone: [(+44 (0)20 3141 8700)]; Email: info@hansonwade.com
  
28.The Strategic Digital Pharma Marketing Course - with Ruud Kooi and Beverly Smet
 Dates 30 Sep 2015 → 01 Oct 2015
[ID=716598] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-digital-marketing-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
29.Value Pricing for Market Access - with Gary Johnson
 Dates 01 Oct 2015 → 02 Oct 2015
[ID=716446] Go to top of page
 LocationLondon, United Kingdom
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-pricing-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
30.Bangladesh R&D Capacity Building 2015
 Dates 03 Oct 2015 → 06 Oct 2015
[ID=697583] Go to top of page
 LocationDhaka, Bangladesh
 Abstract The main aim of the conference will be to assess the existing capabilities in drug discovery and availability of resources within ICGEB member countries in Asia and Africa, to determine further needs and develop a network of research groups possessing complementary expertise and facilities. Invited speakers will be experts in different scientific disciplines required for the discovery and development of drugs. Participants from the ICGEB member countries in Asia and Africa must be actively involved in drug discovery and development research.
 Weblink http://www.icgeb.org/bangladesh-rd-capacity-building-2015.html
  
31.2nd Bioinformatics & Drug Discovery Conference
 Dates 05 Oct 2015 → 06 Oct 2015
[ID=717037] Go to top of page
 LocationBerlin, Germany
 Abstract We are pleased to invite you to the 2nd Bioinformatics & Drug Discovery Conference, which will take place October 5-6, 2015 in Berlin, Germany. The conference will bring together the world’s leading bioinformaticians and discuss developments in NGS big data, cloud systems, clinical and cancer genomics data, and database integration.
 Weblink https://www.gtcbio.com/conferences/bioinformatics-drug-discovery-overview
 Contact Kristen Starkey; Email: infogtcbio@gtcbio.com
 Related subject(s) Genomics and Bioinformatics
  
32.16th INTERNATIONAL CONFERENCE ON ALZHEIMER'S DRUG DISCOVERY
 Dates 05 Oct 2015 → 06 Oct 2015
[ID=723831] Go to top of page
 LocationJersey City, United States
 Abstract This annual Alzheimer's Drug Discovery Foundation (ADDF) conference brings together academic and industry scientists intent on accelerating the development of innovative treatments for Alzheimer’s disease and related dementias. The ADDF’s funded investigators and top level scientists in the field will present on their current research progress and stimulate discussion. The conference offers ample opportunities for collaboration and partnering.
 Topics Alzheimer's, dementia, drug discovery
 Weblink http://www.worldeventsforum.com/addf/addrugdiscovery/index.html
 Contact Sara Classen; Phone: [(212)901-8009]; Email: sclassen@alzdiscovery.org
 Related subject(s) Neurology
  
33.GCC Pharmaceutical Congress
 Dates 05 Oct 2015 → 08 Oct 2015
[ID=687944] Go to top of page
 LocationDubai, United Arab Emirates
 Abstract As pharmaceutical care moves to a more patient- centred model it becomes extremely important to ensure an adequate and professional pharmacy practice. Pharmacists, on one hand, need to ensure maximum use of their skills by embarking on a culture of lifelong learning. On the other hand, it becomes evident that all members of the healthcare system need to cooperate to ensure planning, implementation and monitoring of a therapeutic plan that focusses on effective patient outcome. Therefore and following last year’s successful platform, the GCC Pharmaceutical Congress reinforces the importance of collaboration and dialogue amongst policy makers, stakeholders, regulators and pharmaceutical experts. By sharing up-to-date information and highlighting key solutions with the ultimate purpose to drive the GCC pharmaceutical sector forward.
 Topics Pharma, medicine, medication, safety, hospital, pharmacist, pharmaceutical, healthcare, medical
 Weblink http://www.gccpharmacongress.com/
 Contact Jona Legaspi; Phone: [+971 4 361 9616]; Email: info@gccpharmacongress.com
  
34.Technologies in Drug Discovery Summit Europe
 Dates 05 Oct 2015 → 08 Oct 2015
[ID=716983] Go to top of page
 LocationBerlin, Germany
 Abstract We are pleased to invite you to the Technologies in Drug Discovery Summit Europe, which will take place October 5-8, 2015 in Berlin, Germany. The summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research happening.
 Weblink https://www.gtcbio.com/conferences/technologies-drug-discovery-summit-overview
 Contact Kristen Starkey; Email: infogtcbio@gtcbio.com
  
35.VI InterAmerican Oncology Conference 'Current Status and Future of Anti-Cancer Targeted Therapies'
 Dates 08 Oct 2015 → 09 Oct 2015
[ID=652266] Go to top of page
 LocationBuenos Aires, Argentina
 Abstract The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development.
 Topics NEW ANTICANCER THERAPIES WOMEN´S CANCER GU CANCER GI CANCER LUNG CANCER HEMATOLOGICAL MALIGNANCIES
 Weblink http://www.oncologyconferences.com.ar
 Contact Email: secretariat@oncologyconferences.com.ar
 Related subject(s) Oncology; Hematology
  
36.The Pharma Forecasting Course - with Gary Johnson
 Dates 08 Oct 2015 → 09 Oct 2015
[ID=716428] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-forecasting-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
37.SOS-2015 — Science of Stability Conference 2015
 Dates 12 Oct 2015 → 14 Oct 2015
[ID=728955] Go to top of page
 LocationGroton, United States
 Abstract Establishing and improving the shelf-life of pharmaceuticals, nutraceuticals and other consumer goods is critical for taking product development to the next level. Despite this, fundamental aspects of Stability Science still remain mysterious to many. Join us to learn about the very latest findings from Industry and Academia. While most Stability Conferences focus on regulations and requirements; here at SOS-2015 "It's all about the Science."
 Topics stability, drug stability, stability science, science of stability, its all about the science, pharmaceutical stability, Latest theories on the role of moisture and temperature on chemical reactions in solids, Use of in silico modeling for degradation mechanisms, Recent findings in oxidation chemistry related to peroxides, Amorphous dispersion, Use of accelerated stability for formulation development
 Weblink https://stabilityconference.com
 Contact Elise Napper; Phone: [+1.860.237.5800]; Email: elise.napper@freethinktech.com
  
38.MEPCC — Middle East Pharma Cold Chain Congress
 Dates 12 Oct 2015 → 15 Oct 2015
[ID=719035] Go to top of page
 LocationDubai, United Arab Emirates
 Abstract The combined growth of the biopharmaceutical industry and the globalization of the industry where the products needs to be transported from the origin to the destination at different points requiring controlled temperature to ensure the quality and safety of the products has resulted in numerous challenges for pharmaceutical professionals involved in their procurement, distribution and quality, therefore it is mandatory to understand the best practices for distribution of temperature sensitive products. This is especially important to the GCC as most temperature-sensitive pharmaceuticals are imported and due to the GCC experiencing massive air-cargo growth. It is also imperative that all stakeholders work in closer unison to achieve as few stalls and gaps as possible ensuring a smooth flow from factory to end user thus mitigating risk and ensuring patient safety.
 Topics Cold Chain, Pharmaceutical, Quality Assurance, Logistics, Supply Chain
 Weblink http://www.pharmacoldchainme.com
 Contact Fathima Dhanani; Phone: [+97143619616]; Email: info@pharmacoldchainme.com
  
39.6th Eilat International Educational Course: PHARMACOLOGICALTREATMENT OF EPILEPSY
 Dates 12 Oct 2015 → 16 Oct 2015
[ID=629843] Go to top of page
 LocationJerusalem, Israel
 Abstract The Course is held under the auspices of the ILAE Commission on European Affairs (CEA), Israeli League Against Epilepsy, Citizens United for Research in Epilepsy (CURE) and the Hebrew University of Jerusalem. The program is designed for junior researchers and clinicians (45 years and younger) working in the field of epilepsy treatment and related basic research. It is open to young neurologists, neuropediatricians, pharmacists, pharmacologists, neuropsychologists and neuroscientists. We are happy to inform you that a number of bursaries have been made available towards partially defraying the cost of accommodation expenses of bursary recipients, who will also have their registration fees waived.
 Topics Course Epilepsy Commission Pharmacist Pharmacologists Neuroscientists Research in Epilepsy CURE
 Weblink http://www.eilatedu2015.com/
 Contact Vikky Hyman; Phone: [+972 3 5175150]; Email: eilatedu@target-conferences.com
 Related subject(s) Medicine (in general)
  
40.The 2015 Vaccine Summit
 Dates 13 Oct 2015 → 15 Oct 2015
[ID=685808] Go to top of page
 LocationLondon, United Kingdom
 Abstract Now in its third year, this international interdisciplinary event is an open forum for discussion of all scientific and clinical aspects of vaccine development and vaccinations. Using a multi-professional and inter-specialty approach this event offers plenty of opportunity for networking and debate, and will bring you up to date with current research and thinking.
 Weblink https://www.regonline.co.uk/Vac2015
  
41.Process Scale-Up in the Pharmaceutical Industry
 Dates 14 Oct 2015 → 16 Oct 2015
[ID=731831] Go to top of page
 LocationCologne, Germany
 Topics quality, pharma, process scale-up, optimisation, process development, process validation, digital revolution in Pharma
 Weblink http://pharma.flemingeurope.com/process-scale-up-for-pharma-training?utm_source=listing_conference-service&utm_medium=listing&utm_campaign=BATD150_home
 Contact Andrea Weber; Phone: [+421 257 272 145]; Email: andrea.weber@flemingeurope.com
  
42.Foundation in Paediatric Pharmaceutical Care 5th International Masterclass
 Dates 15 Oct 2015 → 17 Oct 2015
[ID=727710] Go to top of page
 LocationLondon, United Kingdom
 Abstract The paediatric pharmacy team at Evelina London Children’s Hospital are pleased to announce that registration is now open for this year’s Foundation in Paediatric Pharmaceutical Care.  This Fifth International Masterclass will take place on 15-17 October and is intended primarily for overseas pharmacists, with an interest in paediatric pharmaceutical care.  However, UK pharmacists are also encouraged to attend.
 Weblink http://www.guysandstthomasevents.co.uk/paediatrics-training/pharmacy-masterclass-2015/=?src
 Related subject(s) Pediatrics
  
43.9th Vaccine & ISV Congress
 Dates 18 Oct 2015 → 20 Oct 2015
[ID=713283] Go to top of page
 LocationSeoul, South Korea
 Abstract The aim of the 9th Vaccine & ISV Congress is to provide a forum for researchers, professionals and policy makers to present, share and exchange the latest cutting edge discoveries in vaccines and vaccinations. We hope to facilitate new collaborations between experts in the field and inspire new and innovative ideas in vaccine development. The Vaccine & ISV Congress has enjoyed an exciting history covering all aspects of vaccines since 2007. In 2014, we were privileged to hear from Dr Nancy J Sullivan from the National Institutes of Health Vaccine Research Center on developing a novel Ebola vaccine. We are excited to be holding the 9th Vaccine & ISV Congress in Seoul, Korea and invite you to join us to discuss the following topics: The conference will include: Human vaccines - infectious diseases, Human vaccines - non-infectious diseases, Veterinary vaccines, Vaccine safety, Clinical studies and field trials, Immunology / animal models, Vectors / adjuvants / drug delivery, Production / manufacturing, Regulatory / societal / economic / programmatic / legislation subjects, Impact of vaccines upon disease epidemiology, Vaccine delivery technologies.
 Weblink http://www.vaccinecongress.com/
  
44.Chimeric Antigen Receptor Therapy in Haematology and Oncology: Current Successes and Challenges
 Dates 19 Oct 2015 → 20 Oct 2015
[ID=685644] Go to top of page
 LocationCharles Darwin House, London, United Kingdom
 Weblink http://www.biochemistry.org/Conferences/AllConferences/tabid/379/View/Conference/MeetingNo/SA175/Default.aspx
 Related subject(s) Oncology
  
45.Orphan Drugs and Rare Diseases
 Dates 19 Oct 2015 → 20 Oct 2015
[ID=723953] Go to top of page
 LocationLondon, United Kingdom
 Abstract Several thousand different types of rare diseases and disorders exist, with more being discovered each day. In recent years, the interest for rare diseases has grown throughout the entire medical community. However, the road to an approved orphan drug is a long and costly one with many challenges on the way including regulatory, financial, sustainability and pricing and reimbursement issues.
 Weblink http://www.orphandrugs-event.com/conferenceservice
 Contact Sarah Watson; Phone: [+442078276134]; Email: swatson@smi-online.co.uk
 Related subject(s) Medicine (in general); Regulation in Medicine and Pharmacology
  
46.COPD
 Dates 19 Oct 2015 → 20 Oct 2015
[ID=726303] Go to top of page
 LocationLondon, United Kingdom
 Abstract COPD causes 6% of the world’s morbidity and costs the worldwide economy $36 billion and though non curable, it can be tamed through a range of management mechanisms. SMi's 7th annual conference on COPD will bring together respiratory leaders and scientific pioneers to strengthen knowledge in combinational therapies, new drugs and personalised treatment, whilst keeping you at the forefront of scientific breakthroughs to adapt to the growing need for efficiency in the management of exacerbations. Understanding COPD pulmonary indications through biomarkers and the practicalities of reliable clinical trials will be a major focus as will hearing from a selection of pharmaceutical organisations currently developing scientific trials for COPD. This will include case studies from Novartis, Mundipharma, Janssen, MedImmune and Bayer.Exclusive updates into formulation developments and the manufacturing of dry powder inhalation products, lymphoid follicles in COPD and ACOS (Asthma, COPD, Overlap Syndrome) will be just some of the conference highlights this year.
 Topics COPD, Exacerbation, Clinical Trials, Personalized Medicine, Combination therapy, Drug developments, Asthma–chronic obstructive pulmonary disease overlap syndrome (ACOS), NOVEL THERAPEUTICS, biomarkers, respiratory disease, lung disease, lung, chest, thoracic, Endotyping, Comorbidities, pulmonary, rehabilitation, combination therapies, inhaled devices, ectopic follicles, inhalation, Pulmonary Rehabilitation
 Weblink http://www.copd-conference.co.uk/confservice
 Contact Teri Arri; Phone: [+442078276162]; Email: tarri@smi-online.co.uk
 Related subject(s) Pulmonology
  
47.AMS USA 2015 — World Anti-Microbial Congress USA 2015
 Dates 19 Oct 2015 → 20 Oct 2015
[ID=726499] Go to top of page
 LocationWashington, DC, United States
 Abstract The World AntiMicrobial Resistance Congress USA gathers key stakeholders from government, funding agencies, pharma, academia and payers to discuss the urgent need for new antibiotics. President Obama has outlined his 5-year action plan to fight AMR and is seeking to double the AMR funding to $1.2B, but the bigger challenge is how to deliver these actions.This 2-day conference presents solutions through key notes, case study presentations, expert opinion and roundtable discussions, and invites key influencers such as BARDA, NIH, FDA, grant agencies, pharma and academia, in the AMR discussion. This is the 2-day exhibition and conference you cannot afford to miss.
 Topics Private funding for antibiotic research, Generating an antimicrobial from natural products using a molecular approach, Genome mining to achieve novel antibiotic research, screening membrane-active compounds for antibiotic efficacy, and many more
 Weblink http://www.terrapinn.com/conference/antimicrobial-resistance-congress-usa/index.stm?utm_source=COMS&utm_medium=Listing &utm_campaign=COMS Listing
 Contact Freya Smale; Phone: [646-619-1811]; Email: freya.smale@terrapinn.com
  
48.The Pharma Licensing Negotiation Master Class - with Dr. Roger Cox
 Dates 20 Oct 2015 → 21 Oct 2015
[ID=724037] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-licensing-negotiation-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
 Related subject(s) Regulation in Medicine and Pharmacology
  
49.VI International Exhibition of Equipment and Technology for Pharmaceutical Industry PHARMATechExpo
 Dates 20 Oct 2015 → 22 Oct 2015
[ID=727389] Go to top of page
 LocationKiev, Ukraine
 Weblink http://pharmcomplex.com/en/
 Related subject(s) Exhibitions and Trade Shows in Chemistry, Laboratory Technology
  
50.Dos and Don'ts in Health Technology Assessments in the EU - with Prof. Dr. Lieven Annemans
 Start date21 Oct 2015
[ID=716512] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-health-technology-assessment-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
51.Pharma-Biotech Product & Company Valuation - with Dr. Patrik Frei
 Start date22 Oct 2015
[ID=716571] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-product-company-valuation-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
52.COS — Clinical Outsourcing Strategies 2015 3rd Annual Symposium
 Dates 22 Oct 2015 → 23 Oct 2015
[ID=724729] Go to top of page
 LocationFrankfurt, Germany
 Abstract Clinical outsourcing and clinical operations. Assess strategic and tactical CRO management from pre-selection, selection and post clinical trial agreement and accountability. Over 20 sessions covering all aspects of clinical trial outsourcing and clinical operations, 120 capacity and it is the third cycle.
 Topics CRO, Clinical, Outsourcing, Pharma
 Weblink http://www.clinical-outsourcing.com/
 Contact Josepher Chen; Phone: [00 44 (0) 207 096 1152]; Email: josepher.chen@busd.co.uk
 Related subject(s) Clinical trials
  
53.Antibody Drug Conjugates Conference
 Dates 22 Oct 2015 → 23 Oct 2015
[ID=717365] Go to top of page
 LocationBoston, United States
 Abstract We invite you to attend the Antibody Drug Conjugates Conference, which will take place October 22-23, 2015 in Boston, MA. This event will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the emergence of recent data from ADC clinical trials, new linkers and payloads, personalized healthcare, site specific attachment, and ADC therapeutics. With the field of antibody drug conjugates rapidly expanding and the increasing number of ADC clinical trials, novel therapeutics are emerging. The ADC therapeutic area combines synthetic chemistry with rationale biology and is advancing monoclonal antibody treatments into the realm of precision medicine with improved effectiveness and therapeutic indices.
 Topics I. Advances in Protein Modeling and Engineering Breakthroughs II. Novel Payloads and Linker Technology III. Pre-Clinical and Clinical Advances IV. Translational Considerations V. ADC Applications Beyond Oncology
 Weblink https://www.gtcbio.com/conferences/antibody-drug-conjugates-overview
 Contact Kristen Starkey; Phone: [626-256-6405]; Email: infogtcbio@gtcbio.com
 Related subject(s) Biotechnology
  
54.3rd Antibody & Protein Therapeutics Conference
 Dates 22 Oct 2015 → 23 Oct 2015
[ID=717386] Go to top of page
 LocationBoston, United States
 Abstract We welcome you to the 3rd Antibody & Protein Therapeutics Conference, which will be held October 22-23, 2015 in Boston, MA. This conference strives to connect industry and academic researchers in the protein therapeutics field to facilitate discussion on the current state of the industry and discuss recent studies and challenges involved in therapeutic development. Representatives from big pharma, academic institutions and government research labs will present data and case studies on key topics including antibody drug conjugates, bispecific antibodies, antibody combinations, and check point inhibiting antibodies. Attend to learn and network with key opinion leaders in a highly interactive and intimate environment!
 Topics I. Advances in Protein Modeling and Engineering Breakthroughs II. Therapeutic Applications of Antibodies & Proteins III. Novel Bispecific and Multispecific Antibodies & Proteins IV. Preclinical Development and Clinical Trials V. New Target Identification Methods
 Weblink https://www.gtcbio.com/conferences/antibody-protein-therapeutics-overview
 Contact Kristen Starkey; Phone: [626-256-6405]; Email: infogtcbio@gtcbio.com
 Related subject(s) Biotechnology
  
55.2015 American Association of Pharmaceutical Scientists Annual Meeting & Exposition
 Dates 25 Oct 2015 → 29 Oct 2015
[ID=699152] Go to top of page
 LocationOrlando, United States
 Weblink http://www.aaps.org/annualmeeting/
  
56.Biosimilars APAC
 Dates 27 Oct 2015 → 30 Oct 2015
[ID=733118] Go to top of page
 LocationSingapore, Singapore
 Abstract Asia Pacific countries are actively working to formulate biosimilars guidelines and promoting itself as an attractive destination for biosimilar companies to set up manufacturing and R&D facilities. IBC’s Biosimilars Asia Pacific conference evaluates the region’s market readiness and future uptake of biosimilars, development of regulatory frameworks and best practice commercialization strategies. What's New - Biosimilar investment opportunities in Asia Pacific - Strategic market access in regulated and less regulated markets - Latest regulatory developments and approvals in Europe, United States, Southeast Asia and China - Business models and cost effective approaches to advance biosimilar development - Insights on key success factors in a win-win partnership
 Topics biosimilars, biologics, biomanufacturing, biobetters, biotechnology, biopharmaceuticals, biopharma asia, singapore pharmaceuticals, biobetters, biowaivers, Biosimilar investment opportunities
 Weblink http://www.biosimilarsapac.com/
 Contact Rita Parasurum; Phone: [6565082401]; Email: rita.parasurum@ibcasia.com.sg
  
57.11th Annual Project & Portfolio Management in the Pharmaceutical Industry
 Dates 28 Oct 2015 → 29 Oct 2015
[ID=731960] Go to top of page
 LocationVienna, Austria
 Abstract The increasing budget pressures in the pharmaceutical industry and multiple challenges in the drug development have led Pharmaceutical companies to pay far greater attention to their portfolio strategies, resource allocation and decision making processes.
 Topics Project management, portfolio management, drug discovery and development, risk management, risk assessment, portfolio optimization, PPM, internal portfolio, external portfolio, licensing, academia, M&A, mergers and acquisitions, portfolio valuation, patent expiration, productivity pipeline, R&D, portfolio planning, life cycle management, LCM, alliances, academia, innovation, rising R&D costs, budget, pipeline diversification, value proposition, payer, project leadership, ROI, etc.
 Weblink http://pharma.flemingeurope.com/pharma-ppm-conference?utm_source=listing_conference-sevice&utm_medium=listing&utm_campaign=BALS167_home
 Contact Andrea Weber; Phone: [+421 257 272 145]; Email: andrea.weber@flemingeurope.com
  
58.Oman Pharmaceutical Conference 2015
 Dates 28 Oct 2015 → 29 Oct 2015
[ID=742018] Go to top of page
 LocationMuscat, Oman
 Abstract The theme of the conference “Emerging Role of Pharmacists in Health Care System” is so apt in the modern times where the pharmacists play an important role in better patient care and improved drug delivery. The conference will include plenary lectures, symposia and workshops. The conference speakers will highlight the importance of patient counseling, medication errors and Pharmacovigilance in health care. The second day of the conference will be student / young researchers and practitioners centered with the program focused on current and future pharmacy practice and research. Eminent speakers from USA, France, Qatar, Saudi Arabia, India etc. will deliver lectures and conduct workshops for participants. Eminent Scientists from academia, industry and practitioners from Sultanate of Oman will be delivering talks on improved patient care in both acute and chronic health disorders. The highlight of the conference includes workshops on training pharmacy preceptors, paediatric care practice and total parenteral nutrition.
 Weblink http://www.omc.edu.om/Oman_Pharmaceutical_Conference_2015/index.html
 Contact Dr Alka Ahuja; Phone: [0096824504608 ext 192]; Email: alka@omc.edu.om
  
59.11th Annual Sales & Marketing Excellence in Pharma
 Dates 28 Oct 2015 → 30 Oct 2015
[ID=728534] Go to top of page
 LocationBerlin, Germany
 Abstract The era of patient empowerment, patient-driven care and patient centricity is pushing pharmaceutical companies to re-think their sales and marketing strategies. Patients and their support groups are becoming “super- consumers” — capable of making real, value- based decisions based on health outcomes while increasingly taking an important role in driving policy-making. At the same time, sophisticated health information technology is further enabling, and accelerating, an outcomes-driven industry. With these and many other aspects in mind, the Sales & Marketing Excellence Forum will serve as a live platform for discussions on the most relevant topics.
 Topics social media, e-marketing, digital marketing, CLM, CME (continuouos medical education), marketing, mobile marketing, multi-channel marketing, brand experience, detailing, e-detailing, commercial excellence
 Weblink http://pharma.flemingeurope.com/pharma-sales-marketing-conference/request-agenda?utm_source=listing_conference-service&utm_medium=listing&utm_campaign=BALS169_agenda
 Contact Andrea Weber; Phone: [+421 257 272 155]; Email: andrea.weber@flemingeurope.com
  
60.Advanced Protein Aggregation & Characterization
 Dates 29 Oct 2015 → 30 Oct 2015
[ID=732642] Go to top of page
 LocationVienna, Austria
 Abstract Protein Aggregation has become a topic of growing interest in recent years, especially in pharmaceutical research. Protein aggregation is often encountered during late research stages or manufacturing of biopharma.
 Topics protein aggregation, drug prodcts, parameters, aggregates, regulatory affairs, risk management, development stages, Adverse Effects, Critical Process Parameters, Formulation Parameters, Formulation Parameters, Limits of Predictive Experiments
 Weblink http://pharma.flemingeurope.com/protein-aggregation-masterclass?utm_source=listing_conference-service&utm_medium=listing&utm_campaign=BATD127_home
 Contact Andrea Weber; Phone: [+421 257 272 145]; Email: andrea.weber@flemingeurope.com
 Related subject(s) Regulation in Medicine and Pharmacology
  
61.Endocannabinoid Pharmacology Meeting - 2015
 Dates 29 Oct 2015 → 30 Oct 2015
[ID=727657] Go to top of page
 LocationBern, Switzerland
 Weblink http://www.endocannabinoid-pharmacology.ch
  
62.2nd Annual Drug Discovery USA Congress
 Dates 29 Oct 2015 → 30 Oct 2015
[ID=718004] Go to top of page
 LocationBoston, United States
 Abstract Oxford Global’s 2nd Annual Drug Discovery USA Congress brings together over 150 industry leaders to discuss recent developments in drug discovery and medicinal chemistry.
 Topics drug discovery, GPCR, Ion channel, assay development, screening, flow cytometry, high content analysis, medicinal chemistry, PPI, Computational chemistry, discovery chemistry, synthtetic chemistry, drug design, cheminformatics, discovery data
 Weblink http://www.discoveryusa-congress.com
 Contact Guillaume Alonso; Phone: [+44 (0)1865 248 455]; Email: g.alonso@oxfordglobal.co.uk
 Related subject(s) Chemoinformatics and Computational Chemistry
  
63.ECI — Integrated Continuous Biomanufacturing II
 Dates 01 Nov 2015 → 05 Nov 2015
[ID=737806] Go to top of page
 LocationLake Louise,Alberta, Canada
 Abstract The 2nd ICB conference in the series aims to build on the success of the inaugural 2013 event with an expanded scope which includes a review of the state-of-the-art technologies and emerging trends in upstream, downstream, and drug product unit operations. Topics such as facility design, financial modeling, control strategies, and quality and regulatory considerations will also be discussed. The ICB conference is intended to assemble a selected group of leading scientists and engineers from both academia and industry who are actively engaged in or are considering continuous bioprocessing.
 Topics Upstream Processing Downstream Processing Clinical and Commercial Facility Design Integrated Continuous Processing Monitoring and Control Vaccine and Cell Therapy Processing Regulatory Considerations Business Case for Integrated Continuous Bioprocessing
 Weblink http://www.engconf.org/conferences/biotechnology/integrated-continuous-biomanufacturing-ii/
 Contact Arlene Conway; Phone: [212 514 6760]; Email: info@engconfintl.org
  
64.American Association for Laboratory Animal Science 66th National Meeting
 Dates 01 Nov 2015 → 05 Nov 2015
[ID=699258] Go to top of page
 LocationPhoenix, United States
 Abstract Each fall since 1950, the American Association for Laboratory Animal Science has held its annual National Meeting. During the five days of the meeting, members and nonmembers come together to enjoy the workshops, lectures, poster sessions, and exhibits. The program is designed to have topics relevant to the entire membership. Exhibitors have an opportunity to interact with AALAS members from the academic community, research institutions, government organizations, and commercial companies. The AALAS National Meeting is the largest gathering in the world of professionals concerned with the production, care, and use of laboratory animals.
 Weblink http://www.aalas.org/national-meeting
 Related subject(s) Clinical trials; Regulation in Medicine and Pharmacology
  
65.Vaccines R&D-2015 — International Conference on Vaccines Research & Development
 Dates 02 Nov 2015 → 04 Nov 2015
[ID=679383] Go to top of page
 LocationBaltimore, United States
 Abstract United Scientific Group welcomes International Conference on Vaccines Research & Development (Vaccines R&D-2015) in Baltimore, USA during November 02-04, 2015.

The Conference aims at bringing together professors, researchers, scientists, academicians and other professionals in vaccine community to exchange and discuss their original research results, practical development experiences, technological achievements and new ideas for developing future vaccines.

The meeting features highly informative and interactive sessions to encourage the exchange of ideas across a broad range of disciplines including the latest vaccine technologies, product development initiatives being used to develop new or improved vaccines.

 Topics Basic vaccinology, Influenza vaccines/virus, Ebola outbreak, Vaccines discovery development & formulation, Novel vaccines, New vaccine adjuvants, Clinical trials, Emerging infectious diseases, Passive vaccines-therapeutic antibodies against infectious diseases, HIV/AIDS vaccines, Immunoinformatics, Cancer vaccines, HPV vaccines
 Weblink http://www.unitedscientificgroup.com/conferences/vaccines/
  
66.CSDD 2015 — International conference on Clinical Sciences and Drug Discovery
 Dates 02 Nov 2015 → 04 Nov 2015
[ID=731676] Go to top of page
 LocationBaltimore, Maryland, United States
 Abstract Clinical Sciences and Drug Discovery-2015 (CSDD-2015) has been designed to have an insight on the drug discovery and targeted drug delivery systems. It is important that the professionals should meet up on regular basis to interact, network and exchange ideas and concepts. It is only by sharing ideas we develop new one that catalyze technological advancement. This conference is all set to bring together the global industry leaders, policy makers, innovators, public health researchers, pharmaceutical scientists, internists and primary care physicians together on one platform discussing the new opportunities in the transition
 Topics Drug designing, Drug discovery, CNS drug discovery, Cancer targeted drug delivery, Cardiovascular drug discovery, Biomarkers, Biologics, Biopharmaceuticsls, small molecules, Adjuvants, Anti-infectives, Pharmacokinetics, Analytical sciences, Medicinal Chemistry, Medical Imaging, Computer Aided Drug Designing, Clinical trials, Drug efficacy, Toxicology
 Weblink http://www.unitedscientificgroup.com/conferences/clinical-sciences-and-drug-discovery/
 Contact Organizing Secretary CSDD 2015; Phone: [408-426-4833]; Email: drugdiscovery@uniscigroup.org
 Related subject(s) Clinical trials; Biochemistry and Medicinal Chemistry, Toxicology
  
67.Antibiotic resistance and antibiotic alternatives: Looking towards the future
 Dates 03 Nov 2015 → 05 Nov 2015
[ID=685726] Go to top of page
 LocationLondon, United Kingdom
 Abstract This international interdisciplinary event is an open forum for discussion of the rise in antibiotics resistance and the potential utility of various antibiotic alternatives in treating human and animal disease. Using a multi-professional and inter-specialty approach this event promises plenty of opportunity for discussion and debate set in an informal atmosphere.
 Weblink http://www.regonline.co.uk/Antibio2015
 Related subject(s) Human Physiology; Biology
  
68.Vaccines Against Antigenically Variable Viruses
 Dates 05 Nov 2015 → 08 Nov 2015
[ID=702394] Go to top of page
 LocationAmes, United States
 Weblink http://www.extension.iastate.edu/registration/events/conferences/vaavv
  
69.Crossing Biological Barriers - Advances in Nanocarrier Design for Targeted Drug Delivery
 Dates 09 Nov 2015 → 11 Nov 2015
[ID=725786] Go to top of page
 Location01097 Dresden, Germany
 Weblink http://dechema.de/cbb2015.html
  
70.FAST: Functional Analysis & Screening Technologies Congress
 Dates 09 Nov 2015 → 11 Nov 2015
[ID=742611] Go to top of page
 LocationBoston, United States
 Abstract CHI's FAST Congress brings you the latest technologies and research in cellular screening. The Third Annual Phenotypic Drug Discovery meeting will return with new updates and case studies in phenotypic screening, high-content analysis, physiologically-relevant cellular models, chemical genomics and chemical proteomics. The rapidly evolving area of 3D cellular models will be addressed by two back-to-back meetings, with the Inaugural 3D Cell Culture: Organoid, Spheroid, and Organ-on-a-Chip Models meeting focusing on the new predictive cellular models for drug discovery and toxicity assessment. It will review the use of primary and stem cells, complex co-culture cell models, tumor spheroid models, novel organ-on-a-chip models for efficacy and safety screening, functional analysis, and compound profiling. The Third Annual Screening and Functional Analysis of 3D Models meeting will follow with case studies of phenotypic and high-content screening of complex 3D cellular systems for compound and target selection
 Topics tissue models, 3D tissue models, bioprinting, phenotypic drug discovery, organ-on-a-chip, human chips, toxicology, 3D spehroid, 3D culture, in vitro drug discovery
 Weblink http://www.fastcongress.com
 Contact James Prudhomme; Phone: [781-972-5400]; Email: jprudhomme@healthtech.com
  
71.Biological Therapeutics
 Dates 09 Nov 2015 → 13 Nov 2015
[ID=685640] Go to top of page
 LocationOxford, United Kingdom
 Abstract This is a 5 day short course run by the University of Oxford. It can be taken as a stand-alone short course, or as part of the MSc in Experimental Therapeutics.
 Weblink http://www.conted.ox.ac.uk
  
72.Advances in Cell Based Assays
 Dates 10 Nov 2015 → 11 Nov 2015
[ID=726438] Go to top of page
 LocationLondon, United Kingdom
 Abstract SMi Group are thrilled to present the 8th annual conference in the industry leading series, Advances in Cell Based Assays, taking place on 10th & 11th November 2015 in Central London, UK. Due to improvements in detection technology and sensitivity in drug screening, recent reports predict the cell based assays market to reach $4.7 billion in 2016. With a fresh new agenda for 2015, Advances in Cell Based Assays arrives at the perfect time to expand scientific horizons in key topics such as drug toxicity testing, live imaging, 3D modelling, phenotype screening, formulation in assay development, plus much more! We have worked closely with a leading panel of experts such as AstraZeneca, GSK, Pfizer and Johnson & Johnson, to create a packed programme that has been tailored for an audience of professionals working in regenerative medicine using 3D cell based assays and high-throughput technologies. FEATURED SPEAKERS INCLUDE: • Xavier Leroy, Associate Director, Actelion Pharmaceuticals - Conference Chair • Clare Gardner, Senior Scientist, Pfizer • Roderick Beijersbergen, Group Leader, Division of Molecular Carcinogenesis, Netherlands Cancer Institute • Farnaz-Fallah Arani, Senior Group Leader, UCB • Yolanda Chong, Principal Scientist, Johnson & Johnson • Nariman Ansari, Project Leader, Buchmann Institute for Molecular Life Sciences (BMLS) - Goethe University Frankfurt HIGHLIGHTS: • Discover pioneering 3D cell-based assays advancing reliable and physiologically- relevant in vivo data with HCS technologies • New for 2015 - Next generation multidimensional fluorescence imaging and computational quantification • New for 2015 - Learn high content, high throughput phenotypic platforms for neglected tropical diseases For further details visit the website at www.cellbasedassay.co.uk/conferenceservice or contact the team on Tel: +44 (0)20 7827 600 / Email: events@smi-online.co.uk
 Topics Cell based assay, conference, event, stem cells, label free assays, 3D cell culture, cell line, cell signalling, in vivo, preclinical trials, drug R&D, drug development, in vivo drug design, ASSAY, PROTEIN, phenotype screening , Regenerative medicine , flow cytometry, high-content analysis, Molecular Life Science, fluorescence imaging , computational quantification, HTS, HCS, HCA, live cell imaging, Tissue Based Assays, 3D Cell Based, Cellular Assays, 3D Models, through-put SCREENING, toxicity, Phenotype
 Weblink http://www.cellbasedassay.co.uk/conferenceservice
 Contact Teri Arri; Phone: [+442078276162]; Email: tarri@smi-online.co.uk
 Related subject(s) Genomics and Bioinformatics; Molecular Biology
  
73.First SQU International Chemistry Conference: Recent Trends in Drug Development
 Dates 10 Nov 2015 → 12 Nov 2015
[ID=699977] Go to top of page
 LocationMuscat, Oman
 Abstract This event will provide a forum for chemists from around the world to meet, present, and discuss their research, the conference, will highlight contemporary research in drug development from a chemistry standpoint. Participants will have a chance to share their expertise in the field of drug development and identify areas of possible collaboration. Plenary lectures by internationally renowned speakers will be held, and one full session will be dedicated to presentations by graduate students and young researchers.
 Topics Medicinal Chemistry, Natural Products: Isolation & Identification, Total Synthesis, Novel Materials & Drug Delivery, Drug Protein Interaction & Characterization, Young Scientists Session,
 Weblink http://conference.squ.edu.om/Default.aspx?tabid=1246
 Contact John Husband; Phone: [+96824141483]; Email: rtdd2015@squ.edu.om, rtdd2015@gmail.com
 Related subject(s) Biochemistry and Medicinal Chemistry, Toxicology
  
74.1st SQU Conference on Recent Trends in Drug Development
 Dates 10 Nov 2015 → 15 Nov 2015
[ID=705531] Go to top of page
 LocationMucat, Oman
 Weblink http://conference.squ.edu.om/international-chemistry-conference
  
75.GPSS — 1st International Gazi Pharma Symposium Series
 Dates 12 Nov 2015 → 15 Nov 2015
[ID=700971] Go to top of page
 LocationAntalya, Turkey
 Abstract The objective of this international meeting is to further understand about the cancer prognosis, the treatment alternatives, the details of nano pharmaceutics, nano device/delivery systems, some of hot pharmaceutical topics and related regulatory issues, new synthesis, new methods for production, new drug entities and to develop new and specific drug delivery systems.
 Topics ATURAL PRODUCTS CHEMISTRY PHYTOPHARMACY CLINICAL PHARMACY IMPLEMENTATION of QUALITY by DESIGN (QbD) : A REGULATORY PERSPECTIVE COSMETICS AND SAFETY ISSUES ANALYTICAL METHOD DEVELOPMENT: NEW APPROACHES BIOSIMILARS: CHALLENGES AND OPPORTUNITIES NEW STRATEGIES ON LEAD GENERATION&DEVELOPMENT SIGNALING PATHWAYS AS DRUG TARGETS RECENT ADVANCES IN ANTIMICROBIAL THERAPY BIOMARKERS FOR PREDICTING DISEASE AND TOXICITY OF DRUGS STRATEGIES FOR GOOD PHARMACOVIGILANCE PRACTICES EPIGENETICS AND OMICS CHRONOPHARMACOLOGY DRUG DELIVERY AND TARGETING
 Weblink http://www.gpss2015.org
 Contact Erden Banoglu; Phone: [+90 312 202 32 20]; Email: ebanoglu@gmail.com
  
76.2015 NEI Psychopharmacology Congress
 Dates 12 Nov 2015 → 15 Nov 2015
[ID=699234] Go to top of page
 LocationOrlando, United States
 Weblink http://www.neiglobal.com/go/congress
  
77.3rd Steroid Research Congress
 Dates 15 Nov 2015 → 18 Nov 2015
[ID=683432] Go to top of page
 LocationChicago, United States
 Abstract As with previous successful meetings in the series this conference will bring together international delegates to address state-of-the-art approaches in the molecular basis of steroid-related common human diseases. The program will reflect the interdisciplinary nature of steroid research, involving aspects of analytics, chemistry, biology, medicine, bioinformatics and drug discovery.
 Weblink http://www.steroidresearchcongress.com
 Related subject(s) Biology; Endocrinology
  
78.Biosimilars and Biobetters USA
 Dates 16 Nov 2015 → 17 Nov 2015
[ID=735053] Go to top of page
 LocationIselin, United States
 Abstract Through a series of panel discussions, presentations and workshops, Biosimilars & Biobetters USA 2015 will offer effective strategies and solutions for developing cost effective biosimilars for the future. With an in-depth focus on the current and future landscape of the biosimilars market, this year's conference will allow input from key industry experts in the field to engage in meaningful and important discussions on how to accelerate drug development to market.
 Weblink http://www.biosimilars-usa.com/elsevier
  
79.ICI Europe — Immune Checkpoint Inhibitors Europe
 Dates 16 Nov 2015 → 18 Nov 2015
[ID=737753] Go to top of page
 LocationBad Homburg v. d. Höhe, Germany
 Abstract Realise the next generation of immune checkpoint modulators by attending ICI Europe. The Immune Checkpoint Inhibitors Europe conference is crafted to help fast-track the development of your immuno-oncology drug pipeline. Access the latest industry intelligence and be the next to follow Opdivo and Keytruda onto the European market.
 Weblink http://immunecheckpoint-europe.com/
 Contact Katie Draper; Phone: [+44 (0)20 3141 8700]; Email: info@hansonwade.com
 Related subject(s) Human Physiology
  
80.ICPPS 2015 — International Conference on Pharmacology and Pharmaceutical Sciences
 Dates 17 Nov 2015 → 18 Nov 2015
[ID=726783] Go to top of page
 LocationVienna, Austria
 Abstract ICPPS 2015 will bring together innovative academics and representatives of corporations, independent experts in the field of Pharmacology and Pharmaceutical Sciences to a common forum.
 Topics Pharmaceutics, Pharmaceutical Technology, Pharmaceutical Chemistry, Pharmaceutical Analysis, Medicinal Chemistry, Bio-Pharmaceutics, Pharmacology, Toxicology, Genomics and Proteomics, Pharmacognosy, Phytochemistry, Pharmacy Practice
 Weblink http://pharma.conference-site.com
 Contact Elena Ringo; Phone: [+43 676 9673772]; Email: adeo.office@gmail.com
  
81.The Pharma Brand Planning Course - with Edouard Demeire
 Dates 17 Nov 2015 → 18 Nov 2015
[ID=716473] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-brand-planning-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
82.The e-Medical Affairs Course - with Fonny Schenck
 Dates 17 Nov 2015 → 18 Nov 2015
[ID=716646] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-e-medical-affairs-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
83.CHI's Immunogenicity and Bioassay Summit 2015
 Dates 17 Nov 2015 → 19 Nov 2015
[ID=742601] Go to top of page
 LocationBaltimore, United States
 Abstract The summit features opportunities for attendees to gain up-to-the-minute, implementable intelligence to overcome immunogenicity and bioassay challenges. The summit also includes more than 45 sessions, 4 dinner short courses, 12 roundtable breakouts and panel discussions, and an exhibit/poster hall showing the latest solutions. The summit is organized into 3 tracks: Immunogenicity Assessment & Clinical Relevance, Immunogenicity Prediction & Mitigation, and Optimizing Bioassays for Biologics.
 Topics immunogenicity, bioassays, biologics, biosimilars, biotherapeutics, immune response, B and T cell epitopes, bioanalytical development
 Weblink http://www.immunogenicitysummit.com
 Contact James Prudhomme; Phone: [7819725400]; Email: jprudhomme@healthtech.com
 Related subject(s) Biology
  
84.Biosimilars LATAM
 Dates 18 Nov 2015 → 19 Nov 2015
[ID=732073] Go to top of page
 LocationSao Paulo, Brazil
 Abstract This event is an opportunity to gather and meet top representatives from the mayor innovator and biosimilars companies, regulatory authorities across Latin America, USA and EU, and local and international organisations.
 Topics biosimilars, regulation, develpoment, manufacturing, R&D, biobetters, biosuperiors, intellectual property
 Weblink http://pharma.flemingeurope.com/biosimilars-latam-forum?utm_source=listing_conference-service&utm_medium=listing&utm_campaign=BALS164_home
 Contact Andrea Weber; Phone: [+421 257 272 145]; Email: andrea.weber@flemingeurope.com
  
85.PV — 2nd Pharmacovigilance 2015
 Dates 18 Nov 2015 → 19 Nov 2015
[ID=730094] Go to top of page
 LocationLondon, United Kingdom
 Topics Pharmacovigilance, Drug Safety, Pharmacogenomics, Drug Product Safety, Drug Development, Information and Clinical Data Management, Clinical Pharmacology, Clinical Safety, Periodical Safety update Reports, Risk Management, Research and Development, Quality Assurance, Patient Safety, Safety Surveillance, Outcomes Research, Data Analysis, Epidemiology, Medical Affairs, Regulatory Affairs and Compliance, Information Technology, Sales and Marketing, Pharma, Biotechnology, CROs, Software Providers
 Weblink http://www.recunnect.com/pharma-events/pharmacovigilance-2015/
 Contact Jasneet Gulshan; Phone: [02071129183]; Email: jasneet@recunnect.net
 Related subject(s) Biotechnology; Clinical trials
  
86.2nd Pharmacovigilance Conference
 Dates 18 Nov 2015 → 19 Nov 2015
[ID=732865] Go to top of page
 LocationLondon, United Kingdom
 Abstract According to a pubmed publication ‘Drug related admissions have significantly increased over the past few decades. According to various studies on drug related hospital admissions, it was estimated that around 5–10% of hospital admissions were due to drug related problems (DRP), in which 50% of them are avoidable.’Through evaluating and improving the safety of medicines pharmacovigilance serves as a pivot in detection, assessment, understanding and prevention of adverse effects or any other drug-related issues. The volatile global pharma scenario and challenging regulations have invoked quintessential changes in contemporary pharmacovigilance expanding its scope beyond reporting adverse events towards toning benefit-risk systems.
 Topics Adverse Drug Reaction Blood Disorders Clinical Research Clinical Study Clinical Trial Coaching Disease Drug Interaction Drug interactions Drug Recall Drug Shortage Generic Medicine Medicine Coupons Medicine Dosage Medicine Dosages Medicine Reactions Medicine Safe Medicine Shortage Medicine Side Effects New Clinical Trials Periodic Safety Pharmacoepidemiology Pharmacovigilance Signal Detection Signal Detection Methods Signal Investigation
 Weblink http://www.recunnect.com/pharma-events/pharmacovigilance-2015/
 Contact Pranita; Phone: [44 7826 277 567]; Email: pranita@recunnect.net
 Related subject(s) Regulation in Medicine and Pharmacology
  
87.Therapeutic Area Partnerships 2015
 Dates 18 Nov 2015 → 20 Nov 2015
[ID=735226] Go to top of page
 LocationBoston, United States
 Abstract Therapeutic Area Partnerships is a uniquely efficient gathering bringing together decision-makers to assess the most promising drug programs available for partnering in Cardiovascular/Metabolic Diseases, Neuroscience, Anti-Inflammatory/Autoimmune Diseases, Oncology/Immuno Oncology, Infectious and Emerging Diseases, Advanced Therapies (Cell, Gene and Stem Therapies), Orphan and Rare Diseases, and Academic Technology Transfer.
 Weblink http://atnd.it/29902-0
  
88.Business Principles for Medical Science Liaisons - with Edouard Demeire
 Dates 19 Nov 2015 → 20 Nov 2015
[ID=716452] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-medical-science-liaisons-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
89.Late Stage Pharma Lifecycle Management - with Dr. Neal Hansen
 Dates 19 Nov 2015 → 20 Nov 2015
[ID=716574] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-lifecycle-management-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
90.Principles of Patient Adherence - with Prof. John Weinman and Jeremy Sayers
 Start date24 Nov 2015
[ID=716493] Go to top of page
 LocationLondon, United Kingdom
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-patient-adherence-seminar.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
91.The Pharmaceutical Out-licensing Course - with David Scott
 Dates 24 Nov 2015 → 25 Nov 2015
[ID=716447] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-out-licensing-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
92.The Strategic Digital Pharma Marketing Course - with Ruud Kooi and Beverly Smet
 Dates 25 Nov 2015 → 26 Nov 2015
[ID=716531] Go to top of page
 LocationLondon, United Kingdom
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-digital-marketing-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
93.The Pharma Licensing Negotiation Master Class - with Dr. Roger Cox
 Dates 26 Nov 2015 → 27 Nov 2015
[ID=716461] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-licensing-negotiation-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
94.Validation & Transfer of Methods for Pharmaceutical Analysis
 Dates 30 Nov 2015 → 02 Dec 2015
[ID=727902] Go to top of page
 LocationBerlin, Germany
 Abstract v\:* {behavior:url(#default#VML);} o\:* {behavior:url(#default#VML);} w\:* {behavior:url(#default#VML);}. shape {behavior:url(#default#VML);} Normal 0 false false false EN-GB X-NONE X-NONE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Calibri","sans-serif";} This course will provide you with the requisite scientific knowledge and understanding of analytical method validation, verification and transfer to allow informed interpretation of current regulatory guidance from EMA, FDA and ICH, e.g. Q2(R1). Course overview : The data generated using analytical test methods is essential for many of the critical decisions made in the pharmaceutical industry. To be confident in the integrity of this data it is crucial that the methods are fit for purpose. To demonstrate that a method is fit for purpose will require either a validation, verification or transfer study, depending on the source of the method in question. This course provides a detailed explanation of how these studies are performed, enabling a full understanding of method performance characteristics and associated statistics, and how they are applied to the techniques used for analysing drug related samples. Learning Objectives: 1.       Understand the purpose of analytical method validation and the principles of measurement uncertainty. 2.       Define the parameters used for method validation, i.e. the validation characteristics as per ICH Q2(R1) of: specificity, accuracy, range, linearity, precision, detection limit, quantitation limit and robustness. 3.       Generate a validation, verification or transfer protocol, as appropriate, including practically relevant experiments and acceptance criteria. 4.       Interpret the results of validation, verification and transfer studies using appropriate statistics. 5.       Understand the different possible approaches that may be used for analytical method transfer as per available guidance from EMA, USP <1224>, FDA and WHO. 6.       Review analytical procedures in terms of transfer to another laboratory and identify potential problems. Delivery options for this course : The full course takes place over 3 days but if preferred, it is possible to attend the first 2 days only for a method validation course or the last day only for a method transfer and verification course. In the case of attendance on the last day only it is essential that delegates are familiar with validation characteristics since these are used for method transfer and verification. Open-enrolment training courses: You can attend one of our open enrolment training courses at the following locations: �          Hilton Garden Inn Heathrow, London, UK; �          Metro Hotel Dublin Airport, Dublin, Ireland; and �          GLS Campus Berlin, Germany. The courses are available throughout the year, refer to the MTS website for full details. On-site training courses: We can deliver the course at your site including any required customisation to meet your specific requirements. Contact us to discuss your training needs and for a quotation. Use of case studies and real life scenarios : The approach of this course is to focus on the principles of method validation, verification and transfer, thereby enabling application to different types of samples and analytical techniques. Case studies are employed to allow consideration of real life scenarios. Examples relating to small molecule drug substances and formulated products, and to physiochemical methods for biotechnological/ biological products, are included. Particular attention is paid to the most common analytical techniques used for pharmaceutical analysis, e.g., High Performance Liquid Chromatography (HPLC). Delegates are invited to bring along any real life examples that they would like advice on during the training. These may be discussed during group exercises, or, where intellectual property is an issue, privately with the trainer. This course is suitable for:                                         Anyone who needs to understand how methods are validated, verified or transferred, either to design and carry out the investigation, or to interpret the data generated. For example:   �          Analytical chemists; �          Laboratory managers/ supervisors; �          Quality control analysts/ managers; �          Quality assurance managers; �          Regulatory affairs managers; �          etc. Included in the course fees: �          Comprehensive course hand-outs; �          Certificate of Attendance; �          Access to training resources via e-MTS; �          Optional post training assessment (leading to Certificate of Training); �          Post training support; �          A copy of the MTS training book, Validation of Analytical Methods for Pharmaceutical Analysis ; �          Lunch and refreshments (for open-enrolment courses only). Course Agenda & Outline Day 1 Timings (approximate): Content: 0900 to 1030 Introduction: �          The purpose of validation in the pharmaceutical industry. �          Available guidelines for method validation, e.g. ICH Q2(R1), FDA, etc. �          The types of analytical methods for pharmaceutical analysis that require validation. �          Definition of analytical method validation characteristics. 1030 to 1045 Refreshment break 1045 to 1130 Uncertainty in Analytical Measurement �          Sources of uncertainty; �          Method validation and uncertainty; �          Assessing measurement uncertainty. 1130 to 1230 Statistics for method validation: �          The mean, the standard deviation and confidence intervals – definition and calculation. �          Student’s t-distribution for small sample sets. �          Test for outliers in method validation – Dixon’s test. �          Statistical significance and comparative studies in method validation – Student’s t-test. 1230 to 1315 Lunch 1315 to 1500 Validation characteristics, as defined in ICH Q2(R1): �          Specificity – discussion of specificity and selectivity for qualitative and quantitative analytical methods; investigation of specificity/selectivity; performing stress studies; peak purity for chromatographic methods. 1500 to 1515 Refreshment break 1515 to 1635 �          Accuracy – the relationship between accuracy and trueness; preparation of recovery samples for different types of drug-related samples and inherent problems; experimental procedure; recovery calculations; acceptance criteria. 1635 to 1645 �          Range – ranges to validate for different types of pharmaceutical analytical methods; required reporting thresholds for impurities analysis.   Day 2 Timings (approximate): Content: 0900 to 1030 Validation characteristics continued: �          Linearity – verification of the calibration method; single point and multi-level calibration; regression analysis and associated statistics; use of residuals; when to use weighting; combined assay and impurities methods; experimental procedure. 1030 to 1045 Refreshment break 1045 to 1230 �          Precision (repeatability, intermediate precision & reproducibility) - the relationship between accuracy, trueness and precision; choosing suitable samples for precision; options if homogenous material is not available, acceptance criteria, Analysis of Variance (ANOVA). 1230 to 1315 Lunch 1315 to 1500 �          Detection limit & quantitation limit – methods of determination; contrast of instrument and practical limits; experimental procedure; acceptance criteria. �          Robustness – relevance in validation studies; factors and levels for investigation; experimental design for robustness investigations; stability of test solutions. 1500 to 1515 Refreshment break 1515 to 1635 Validation protocol: �          Choosing validation characteristics for different types of analytical methods; �          Designing experimental procedures for validation studies – number of replicates, concentration of test solutions and number of concentration levels; �          Setting appropriate acceptance criteria for each validation characteristic; �          Verification of pharmacopeia methods; �          Method validation during drug development and ways to reduce validation testing; �          Execution of the validation protocol. 1635 to 1645 Overview of analytical method transfer: �          Regulatory guidance, e.g. USP <1224>. �          Types of transfers and setting up suitable protocols including experiments and acceptance criteria.   Day 3 Timings (approximate): Content: 0900 to 1030 The requirements for method transfer in the pharmaceutical industry. Different approaches to transfer: �          Comparative testing; �          Co-validation between two or more laboratories; �          Revalidation; and �          Transfer waiver. The role of risk analysis in transfer. Review of available regulatory guidance for method transfer, e.g., USP <1224> Transfer of Analytical Procedures, EMA, WHO, FDA. Main steps in method transfer. 1030 to 1045 Refreshment break 1045 to 1230 Review of the method being transferred in terms of: �          The adequacy of the content of the method and how it is written; �          Potential technical challenges; and �          Existing method knowledge and robustness. Training requirements during method transfer studies. 1230 to 1330 Lunch 1315 to 1500 Preparation of the transfer protocol in compliance with available regulatory expectations, to include: �          Required materials, e.g., drug samples, reference standards; �          Experimental procedure, e.g., numbers of batches and replicates; �          Method performance (validation) characteristics to investigate; and �          Suitable acceptance criteria. 1500 to 1515 Refreshment break 1515 to 1630 Comparison of data from transfer study: �          Non-statistical approaches; and �          Comparative statistical tests which may be used e.g., Student's t-test, two one-sided t-tests (TOST). Carrying out the method transfer experiments. Preparation of the transfer report. Common problems encountered during method transfer and how to resolve them.  
 Weblink http://www.mournetrainingservices.co.uk/course_list.html
  
95.Principles of Pharma Market Access in Europe - with Lloyd Morgan and Mark Silvey
 Dates 01 Dec 2015 → 02 Dec 2015
[ID=716432] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-market-access-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
96.Health Economics for Pharmaceutical Personnel
 Dates 01 Dec 2015 → 02 Dec 2015
[ID=702455] Go to top of page
 LocationLondon, United Kingdom
 Abstract This course is aimed at those working in the pharmaceutical industry needing to be introduced to the language of economics and economic evaluation.
 Weblink http://www.healthcare-ed.com
 Related subject(s) Healthcare Systems; Epidemiology & Public Health
  
97.Genetic Rx Boston
 Start date03 Dec 2015
[ID=699200] Go to top of page
 LocationBoston, United States
 Abstract Genetic Rx will take place at Harvard Medical School and will bring together academics and key industry leaders to discuss the emergence of new genetic medicines as well as the treatment of patients with rare and ultra-rare genetic diseases.
 Weblink http://bbbiotechconference.com/conference-details.php?id=35
 Related subject(s) Medicine (in general)
  
98.Value Pricing for Market Access - with Gary Johnson
 Dates 03 Dec 2015 → 04 Dec 2015
[ID=716434] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-pricing-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
99.Dos and Don'ts in Health Technology Assessments in the EU - with Prof. Dr. Lieven Annemans
 Start date04 Dec 2015
[ID=716577] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-health-technology-assessment-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
100.RDMBSBDD 2015 — Recent Developments in Medical Biotechnology and Structure Based Drug Designing’
 Dates 06 Dec 2015 → 07 Dec 2015
[ID=717344] Go to top of page
 LocationGuwahati, India
 Abstract RDMBSBDD 2015 being organized from December 6th to 7th, 2015 at the Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, India. The two days event will have keynote and invited lectures from renowned scientists and academicians along with oral and poster presentations by students. The conference will cover lectures related to communicable, and non-communicable diseases as well as Structure-Based Drug Design (SBDD). SBDD is one of the most popular and used methods in the rational drug design tools. RDMBSBDD 2015 will provide an excellent platform to keep up with the cutting-edge research as well as information exchange and networking among researchers. We cordially invite you to submit your posters and participate in the conference.
 Weblink http://www.iitg.ernet.in/vdubey/rdmbsbdd2015/Index.html
 Contact Dr. Vikash Kumar Dubey; Phone: [+91 361 2582203]; Email: rdmbsbdd2015@gmail.com
 Related subject(s) Biotechnology; Molecular Modeling
  
101.The First Saudi International Lab Expo 2015
 Dates 06 Dec 2015 → 08 Dec 2015
[ID=698851] Go to top of page
 LocationRiyadh, Saudi Arabia
 Abstract Saudi Arabia’s health sector is advanced and rapidly growing. Most medical institutions in the Kingdom are equipped with the latest medical technologies and this includes labs. The First Saudi International Lab Expo 2015 will be held at Riyadh International Convention and Exhibition Center to give visitors a unique opportunity to experience the latest developments in lab technologies. More than 150 exhibitors from 140 countries have already confirmed their participation, spanning multiple industry sectors and including companies offeringanalytical and lab technologies, biotechnology and life sciences, drug recovery and research, clinical diagnostic and analysis, research and development and others.
 Weblink http://www.saudilabexpo.com
 Related subject(s) Medicine (in general); Exhibitions and Trade Shows in Chemistry, Laboratory Technology
  
102.First international student congress of research integrity and evidence based practice
 Dates 07 Dec 2015 → 09 Dec 2015
[ID=729217] Go to top of page
 Locationkish island, Iran
 Abstract It would be a great honor for Iranian evidence-based medicine center of excellence, Tabriz university of Medical Sciences to host students with innovative ideas and creative minds from all around the world to discuss the approaches, barriers, recent challenges and emerging issues in achieving the best practice and research integrity. The congress will be held for three days, from 7 to 9 December, 2015 in Kish International Convention Center with hundreds of oral and poster presentations.
 Weblink http://www.ebmcongress.com
 Contact Email: congress.ebm@gmail.com
 Related subject(s) Medicine (in general); Healthcare Systems
  
103.The Pharma Business Development Course - with Martin Austin
 Dates 08 Dec 2015 → 09 Dec 2015
[ID=716627] Go to top of page
 LocationLondon, United Kingdom
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-business-development-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
104.Health Economics for Non-Health-Economists - with Prof. Dr. Lieven Annemans
 Dates 10 Dec 2015 → 11 Dec 2015
[ID=716557] Go to top of page
 LocationBrussels, Belgium
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-health-economics-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
105.The Pharma Forecasting Course - with Gary Johnson
 Dates 10 Dec 2015 → 11 Dec 2015
[ID=716383] Go to top of page
 LocationLondon, United Kingdom
 Weblink http://www.celforpharma.com/pharma-management/training/pharma-forecasting-course.html
 Contact Annelies Swaan, Marketing & Sales Manager; Phone: [+32 (0)2 709 01 42]; Email: annelies.swaan@celforpharma.com
  
106.The Biomarker Conference
 Dates 10 Dec 2015 → 11 Dec 2015
[ID=732184] Go to top of page
 LocationOrlando, United States
 Abstract At 'The Biomarker Conference' to be held on 10 - 11 December 2015 in Orlando, Florida, USA 150+ biomarker experts will be gathering to discuss emerging pathways and breakthroughs in biomarker discovery and successful validation in consort with the regulatory guidelines and evolving cost-effective technologies that can help increase success rates in novel biomarker discovery and approvals for clinical utility.
 Topics florida, biomarker discovery, biomarker validation, biomarkers in clinical trials, companion diagnostics, biobank research, clinical oncology, preclinical safety, pharmacogenomics, pharmacogenetics, drug discovery, genomics, bio-informatics, personalized medicine, translational research, biomarkers toxicity, molecular informatics, biomarker imaging, epigenetics biomarkers, systems biology, december, usa, orlando, conferences, summit, expo, congress, Pfizer, Roche, Janssen Research & Development, Novartis Institutes For BioMedical Research, Astrazeneca, Merck Serono, Harvard Medical School, The Wistar Institute, National Cancer Institute, National Institutes Of Health, Moffitt Cancer Center
 Weblink http://www.mnmconferences.com/the-biomarker-conference-florida.html
 Contact Ajay Nimbalkar; Phone: [+912067046816]; Email: ajay.nimbalkar@mnmconferences.com
 Related subject(s) Genomics and Bioinformatics
  
107.NGS Data Analysis and Informatics Conference
 Dates 10 Dec 2015 → 11 Dec 2015
[ID=732279] Go to top of page
 LocationOrlando, United States
 Abstract Growing collaborations between organisations and increased NGS data sharing between locations has created a need for a more robust and secure data storage, analysis, access and integration system while ensuring high quality of the NGS data being produced. At the ‘NGS Data Analysis and Informatics Conference' to be held on 10 - 11 December 2015 in Orlando, Florida - USA we will be discussing strategies to accurately analyse and scale-up informatics for the data generated through the NGS technology while ensuring quality & scalability of the data.
 Topics NGS, next generation sequencing, precision medicine, biomarkers, genome studies, drug discovery, clinical diagnosis, data analysis, computational biology
 Weblink http://www.mnmconferences.com/ngs-data-analysis-informatics-congress-usa.html
 Contact Ajay Nimbalkar; Phone: [((+912067046816))]; Email: ajay.nimbalkar@mnmconferences.com
 Related subject(s) Genomics and Bioinformatics; Systems Biology and Computational Biology
  
108.2nd International Symposium on Clinical Pharmacology of Antimalaria Agents
 Dates 14 Dec 2015 → 15 Dec 2015
[ID=713192] Go to top of page
 LocationAccra, Ghana
 Weblink http://www.regonline.com/register/checkin.aspx?eventid=1552035
 Related subject(s) Medicine (in general)
  
109.Pharmacology 2015
 Dates 14 Dec 2015 → 17 Dec 2015
[ID=727517] Go to top of page
 LocationLondon, United Kingdom
 Abstract Summary:   Pharmacology  attracts over 1,000 scientists each year, mostly from the UK but also many from across Europe and from overseas. The meeting includes a selection of topical symposia, plenary lectures, free oral communications and poster sessions which cover the many aspects of pharmacology from basic to clinical science.
 Weblink http://www.bps.ac.uk/meetings/Pharmacology2015
  
110.Pharmacology 2015
 Dates 15 Dec 2015 → 17 Dec 2015
[ID=707852] Go to top of page
 LocationLondon, United Kingdom
 Abstract British Pharmacological Society's flagship annual meeting.
 Weblink http://www.bps.ac.uk/meetings/Pharmacology2015
  
111.International conference on "Cutting-Edge Pharmacology: Contemporary Issues and Future Challenges"
 Dates 18 Dec 2015 → 20 Dec 2015
[ID=727832] Go to top of page
 LocationRAJKOT, India
 Abstract International conference on ‘Cutting-Edge Pharmacology: Contemporary Issues and Future Challenges’  & 48th Annual Conference of Indian Pharmacological Society (IPSCON-2015) will be held from December 18-20, 2015 at Department of Pharmaceutical Sciences, Saurashtra University, Rajkot, Gujarat, India.
 Weblink http://www.ipscon2015.org
  
112.Biobanking 2016
 Dates 05 Jan 2016 → 07 Jan 2016
[ID=661035] Go to top of page
 LocationLondon, United Kingdom
 Abstract This three day event brings together biomedical and biopharmaceutical researchers, regulators, biorepository managers, and practitioners to look at current practices regarding the banking of biospecimens used for basic research through clinical trials
 Weblink https://www.regonline.co.uk/banking2015
 Related subject(s) Clinical trials; Regulation in Medicine and Pharmacology
  
113.Drug Development, Pharmacokinetics and Imaging
 Dates 18 Jan 2016 → 22 Jan 2016
[ID=724479] Go to top of page
 LocationOxford, United Kingdom
 Abstract This five-day course touches on the basic principles of designing and identifying new drug molecules improving their properties, and monitoring their effect in cellular model systems and in vivo. The course comprises principles of medicinal chemistry, structural biology, structure-based design, in vitro and cell based screening technology, as well as principles of pharmacokinetics and optimisation of drug in vivo properties.
 Weblink https://www.conted.ox.ac.uk/courses/details.php?id=O15C264B9Y
 Contact Course Administrator; Phone: [01865 286955]; Email: expther@conted.ox.ac.uk
  
114.5th Annual International Convention of Association of Pharmacy Professionals
 Dates 22 Jan 2016 → 23 Jan 2016
[ID=737604] Go to top of page
 LocationTIRUCHIRAPPALLI, India
 Weblink http://www.appconnect.in/web-links/upcoming-events/
  
115.Novel Immunotherapeutics Summit
 Dates 25 Jan 2016 → 26 Jan 2016
[ID=738632] Go to top of page
 LocationSan Diego, United States
 Abstract We invite you to GTCbio's Novel Immunotherapeutics Summit, which takes place on January 25 - 26, 2016 in San Diego, CA. The summit will bring together our usual balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain a fresh perspective on the various topics below.
 Topics Cytokines & Inflammation, Immunotherapeutics & Immunomonitoring, Immunogenicity & Immunotoxicity, Allergy, Asthma, & COPD
 Weblink https://www.gtcbio.com/conferences/immunotherapeutics-summit-overview
 Contact Kristen Starkey; Phone: [626-256-6405]; Email: infogtcbio@gtcbio.com
 Related subject(s) Infectious disease medicine
  
116.6th Annual Pharmacovigilance & Risk Management Strategies Forum
 Dates 27 Jan 2016 → 29 Jan 2016
[ID=732125] Go to top of page
 LocationMunich, Germany
 Abstract The ever changing global and local regulatory demands have put a lot of stress on the pharmaceutical, biotech companies and all stakeholders involved. Companies are looking for effective tools to meet the increasing regulatory demands and harmonise PV activities.
 Topics Pharmacovigilance, Pharmacology, Pharmacoepidemiology, Risk Management, Drug Safety, Signal Detection, Data Mining, Benefit/Risk Assessment, QPPV, Medical Affairs, Medical Information, Regulatory Affairs, R&D, Clinical Safety, Quality Assurance, Inspections, Audits, PSMF
 Weblink http://pharma.flemingeurope.com/pharmacovigilance-risk-strategies-forum?utm_source=listing_conference-service&utm_medium=listing&utm_campaign=BALS175_home
 Contact Andrea Weber; Phone: [((+421 257 272 155))]; Email: andrea.weber@flemingeurope.com
 Related subject(s) Regulation in Medicine and Pharmacology; Clinical Data Management
  
117.icddt — 7th International Conference on Drug Discovery and Therapy
 Dates 15 Feb 2016 → 18 Feb 2016
[ID=723307] Go to top of page
 LocationDubai, United Arab Emirates
 Abstract The 7th ICDDT will highlight cutting-edge advances in all major disciplines of Drug Discovery and Drug Therapy. This four-day event will feature recent findings from leading industrial, clinical and academic experts in the field, in the form of lectures and posters. The 7th ICDDT will be unique in promoting the translational nature of modern biomedical and pharmaceutical research, with both scientists and clinicians associated with either patient care or with drug discovery research. A number of Nobel Laureates will deliver keynote lectures at the conference. It will bring together leading clinicians, medicinal chemists, pharmacologists, biotechnologists, and other allied professionals to discuss and present the latest important developments in drug discovery and therapeutics.
 Weblink http://www.icddt.com/home.php
 Contact Qasit; Phone: [(+971-6-5575783)]; Email: marketing@icddt.com
  
118.LDN 2016 — The LDN 2016 AIIC Conference
 Dates 19 Feb 2016 → 21 Feb 2016
[ID=725314] Go to top of page
 LocationOrlando, United States
 Abstract The LDN AIIC 2016 Conference is produced by the LDN Research Trust, a non-profit, Registered Charity dedicated to raising awareness as well as funding research and clinical trials of LDN as a treatment for Crohn's Disease, Colitis, Autism, IBS, Lupus, Fibromyalgia, Rheumatoid, Arthritis, Chronic Pain and other auto-immune diseases. The central role of the conference is to review, compare and contrast the most recent LDN-related data and treatments. It also offers compelling examples, experiences and case studies from many of the world’s leading experts, practitioners and patients who are using LDN to achieve positive, and in many cases, life-changing results.
 Topics LDN, MS, Chrohns, Fibromyalgia, Chronic Pain, Autism, Colitis, ME/CFS
 Weblink http://www.ldn2016.com
 Contact Jim Warner; Phone: [+1 770-663-8803]; Email: jim.warner@ldn2016.com
 Related subject(s) Neurology; Medicine (in general)
  
119.G Protein-Coupled Receptors: Structure, Signaling and Drug Discovery
 Dates 21 Feb 2016 → 25 Feb 2016
[ID=739997] Go to top of page
 LocationKeystone, United States
 Abstract The field of G protein-coupled receptors has recently seen major advances in high-resolution structure determination, as well as the validation of novel paradigms of drug action, such as allosteric modulation and biased agonism, as likely universal mechanisms. These studies are opening new insights into the diversity of this receptor superfamily, teaching us new lessons in receptor functionality and hinting at novel avenues to investigate. At the same time, we are seeing exciting discoveries in GPCR intracellular signaling and physiology. The timing is right to bring together researchers in these different areas. This Keystone Symposia meeting will focus on the interplay between these discoveries and how they are being used to advance GPCR-based research toward improved clinical outcomes. 
 Weblink http://www.keystonesymposia.org/16B3
 Related subject(s) Molecular Biology
  
120.Africa Pharmaceutical Summit
 Dates 24 Feb 2016 → 25 Feb 2016
[ID=725707] Go to top of page
 LocationNairobi, Kenya
 Abstract In its 3rd year, the Africa Pharmaceutical Summit (APS) is now established as the most strategic industry event in the region that brings together all major stakeholders – industry leaders, policy-makers, regulators, academics, investors, scientists and patient representatives, to tackle the most pressing issues the industry is facing and enhance multi-stakeholder cooperation on issues relating to pharmaceutical sector development in this fast growing region of the world. Building a competitive agenda can have a major influence on investment decisions, and is an ideal platform for the pharmaceutical industry to invest, contributing to the health of everyone living in Africa, and to the local economies. A sophisticated partnership and regular dialogue between industry and government adds value to this agenda. A UNIQUE PLATFORM AND IDEAL MEETING PLACE, IN A FAST GROWING REGION OF THE WORLD, FOR POLICY MAKERS, SENIOR PHARMACEUTICAL AND HEALTHCARE INDUSTRY EXECUTIVES, INVESTORS AND STAKEHOLDERS
 Weblink http://africapharmasummit.com
  
121.Pharmacodynamics, Biomarkers and Personalised Therapy
 Dates 29 Feb 2016 → 04 Mar 2016
[ID=714541] Go to top of page
 LocationOxford, United Kingdom
 Abstract The Pharmacodynamics, Biomarkers and Personalised Therapy course is a one-week module of the MSc in Experimental Therapeutics. Offered by the Department of Oncology and the Department for Continuing Education’s CPD Centre, the week will be led by Dr Elaine Johnstone, Senior Research Fellow at the University of Oxford, and will feature face-to-face lectures and tutorials from some of Oxford's leading clinicians and scientists, as well as a practical visit to one of Oxford's research laboratories.The module can be taken as a stand-alone short course. It includes group work, discussions, guest lectures, and interaction and feedback with tutors and lecturers.
 Weblink https://www.conted.ox.ac.uk/courses/details.php?id=B900-28
 Contact Course Administrator; Phone: [01865 286955]; Email: expther@conted.ox.ac.uk
  
122.Pharmacokinetics for Pharmaceutical Scientists Course
 Dates 29 Feb 2016 → 04 Mar 2016
[ID=725776] Go to top of page
 LocationSan Francisco, United States
 Weblink http://dbts.ucsf.edu/pkcourse/
  
123.Antibodies as Drugs
 Dates 06 Mar 2016 → 10 Mar 2016
[ID=740104] Go to top of page
 LocationWhistler, Canada
 Abstract Monoclonal antibodies have had a pronounced impact in medicine and biology, with a broad array of approved agents that are used for the diagnosis, treatment and characterization of cancers, immunological disorders, and infectious diseases. Because of their exquisite target specificities, together with their favorable pharmacologic properties, antibodies are destined to have even increased clinical impact, particularly in diseases that are understood at the molecular level. This Keystone Symposia meeting will focus attention on many of the key advances in antibody-based technologies as well as on where the field is heading. Some of the critical topics to be covered include: 1) Antibody structure and function; 2) Engineered antibodies and antibody-like molecules for improved efficacy; 3) Antibody pharmacologic properties and biologic distribution; 4) Antibody-based therapies for cancer and infectious diseases; 5) Targeting costimulatory pathways and immunological checkpoints; 6) Antibodies as carriers of drugs, cytokines, radioisotopes and imaging agents; 7) Antibody mimetics; 8) Clinical advancements and challenges. This meeting has become an established forum that attracts both new investigators and leaders in the field, coming from academia, industry and research institutes around the globe. The goals of the meeting will be to address the critical issues facing the broad field of antibody-based therapeutics, provide an overview of recent advances and bring together interdisciplinary groups for the generation of new ideas and promising areas of investigation. This meeting is being held jointly with  Cancer Vaccines: Targeting Cancer Genes for Immunotherapy.
 Weblink http://www.keystonesymposia.org/16X2
 Related subject(s) Oncology
  
124.BMCS Mastering MedChem II: 2nd RSC-BMCS symposium on mastering medicinal chemistry
 Start date09 Mar 2016
[ID=740226] Go to top of page
 LocationHuddersfield, United Kingdom
 Abstract This meeting is aimed at all those who wish to become better drug hunters and heed warnings from the past.
 Weblink http://www.maggichurchouseevents.co.uk/bmcs
  
125.5th RSC / SCI symposium on Ion Channels as Therapeutic Targets
 Dates 14 Mar 2016 → 15 Mar 2016
[ID=740269] Go to top of page
 LocationCambridge, United Kingdom
 Abstract Ion Channels are important targets for therapeutic intervention due to their extensive roles in human physiology and the pathophysiology of disease. Many successful drugs targeting ion channels have been discovered for diseases such as hypertension, epilepsy and chronic neuropathic pain, but few were rational designed until recently.
 Weblink http://www.maggichurchouseevents.co.uk/bmcs
  
126.21st Congress of the EAHP
 Dates 16 Mar 2016 → 18 Mar 2016
[ID=727563] Go to top of page
 LocationVienna, Austria
 Abstract "Hospital Pharmacists taking the lead – partnerships and technologies" will be the theme for the presentations at the Vienna 2016 EAHP Congress. A scientific programme including 3 keynote presentations, 15 seminars EAHP’s Congress is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education, as well as by some of its national member associations according to the different national accreditation systems. open for interactions with the speakers and 6 interactive workshops will offer participants the unique opportunity to meet, network and share expertise. EAHP’s industry partners have also committed to conducting satellite symposia highlighting new developments important to hospital pharmacy.
 Weblink http://www.eahp.eu/congresses
  
127.The Second Menactrims Congress — MENACTRIMS (Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis)
 Dates 17 Mar 2016 → 19 Mar 2016
[ID=742682] Go to top of page
 LocationAmman, Jordan
 Abstract The congress aim is to provide a forum of excellence in MS education and research. Building on the collective efforts of the scientific committee, the meeting will deliver state-of-the-art presentations on MS by renowned international and regional keynote speakers. The content of the meeting includes up to date information on the latest treatments, clinical research, therapeutic strategies, imaging, epidemiology, differential diagnosis, risk factors, pregnancy, and much more.The congress will convene over a two-day period to present major updates through plenary sessions, scientific symposia and teaching courses. This year’s congress will also feature parallel sessions addressed to nurses in collaboration with the International Organization of MS Nurses (IOMSN) and the Consortium of Multiple Sclerosis Centers (CMSC), and to regional MS societies in collaboration with the MS International Federation (MSIF). In addition, the European Charcot Foundation will participate in the meeting for the first time through a scientific symposium.
 Topics • Recent advances in MS therapy • MS and the Environment • Update review of MRI in MS • Immunology of MS • Epidemiology of MS • Differential Diagnosis of MS • Update on Secondary Progressive MS • Neuromyelitis Optica • Pediatric MS • MS and pregnancy • Symptomatic Management of MS
 Weblink http://www.diaedu.com
 Contact Basil kadara; Phone: [+971 4 453 2975]; Email: contact@diaedu.com
 Related subject(s) Medicine (in general); Nursing
  
128.HIV Vaccines
 Dates 20 Mar 2016 → 24 Mar 2016
[ID=740219] Go to top of page
 LocationOlympic Valley, United States
 Abstract HIV Persistence: Pathogenesis and Eradication. The development of a safe and effective HIV vaccine remains a major global health priority and a complex problem to solve. Current efforts emphasize an ability to elicit systemic and mucosal antibody responses capable of preventing the acquisition of infection. Evidence from multiple passive transfer experiments in non-human primates, as well as from studies of immunologic correlates of modest efficacy in the RV144 Thai trial, support the notion that both neutralizing and non-neutralizing antibodies have potential to prevent infection. Major advances have been made in understanding the epitopes, structures and evolutionary pathways of broadly neutralizing antibodies, leading to new avenues to pursue for vaccine design. The extraordinary breadth and potency of some recently discovered neutralizing antibodies has generated additional interest in potential therapeutic applications, including cure strategies. There has also been a steady increase in knowledge of other types of antiviral antibodies and their effector functions that may be important for vaccines. This meeting aims to cover a range of topics including: 1) Initial virus transmission events for vaccine intervention, 2) Non-neutralizing antibody correlates of sterilizing immunity; 3) Epitopes, structures and ontogeny of broadly neutralizing antibodies; 4) Novel vaccine concepts for broadly neutralizing antibody induction; and 5) Immunotherapy. Emphasis will be placed on recent unpublished findings in key areas that hold the greatest promise for rapid progress toward an effective vaccine.
 Weblink http://www.keystonesymposia.org/16X8
 Related subject(s) Infectious disease medicine
  
129.Oligo 2016
 Start date06 Apr 2016
[ID=740205] Go to top of page
 LocationOxford, United Kingdom
 Abstract We are delighted to announce our second Oxford Symposium on antisense and therapeutic oligonucleotides.  The symposium is aimed at bringing together chemists and biologists from academia and industry to discuss the latest advances and breakthroughs in the development of synthetic oligonucleotides as therapeutics.
 Weblink http://www.lpmhealthcare.com/oligo-2016-oxford/
 Related subject(s) Molecular Biology; Medicine (in general)
  
130.3rd Annual Peptides Congress
 Dates 18 Apr 2016 → 19 Apr 2016
[ID=742889] Go to top of page
 LocationLondon, United Kingdom
 Abstract Oxford Global’s highly anticipated event offers a unique opportunity for over 400 biologics experts to discuss novel peptide research results and case studies in peptide therapeutics. Co-located with the highly established Proteins & Antibodies Congress and Biosimilars & Biobetters Congress.
 Topics Peptide synthesis, Peptide manufacturing, Peptide development, Peptide research, Peptide technologies, Peptide applications, Peptide formulation, Peptide arrays, Peptide modification
 Weblink http://www.peptides-congress.com/
 Contact Guillaume Alsonso; Phone: [+44 (0)1865 248455]; Email: g.alonso@oxfordglobal.co.uk
  
131.World Orphan Drug Congress USA 2016
 Dates 20 Apr 2016 → 22 Apr 2016
[ID=728969] Go to top of page
 LocationWashington, DC, United States
 Abstract This is the largest global industry gathering for the orphan drug industry and rare disease community where pharma, biotech, patient groups, academia, regulators, payers and investors gather to talk about strategies to expedite orphan drug development. We grew the event to 600 participants in 2015 with over 25 countries represented. cademic medical centers, HCPs, clinicians and point of care diagnostics will be a new focus in 2016. Specific orphan products and their Marketing Managers will also be a stronger focus along with gene therapy as the future rare disease cure. Meet CEOs, VPs and Directors of the following business units from pharma and biotech: R&D, Business Development, Regulatory Access, Market Access, Commercial, Marketing and Brand/Product Managers.You will also meet Scientists, Investigators and Engineers as well as relevant Heads from university departments studying rare disease and developing a cure.
 Topics In terms of content, people are talking more and more about gene therapy orphan drugs. 2016 will feature the latest content on gene therapy orphan drugs in development. The other new addition to 2016 is a workshop for clinicians. This workshop is designed to enable marketers to help clinicians get educated on rare diseases and orphan drugs so they can detect and diagnose rare diseases better and faster.
 Weblink https://secure.terrapinn.com/V5/step1.aspx?E=8006&&utm_source=Conference Service&utm_medium=Listing&utm_campaign=COMSListing
 Contact Freya Smale; Phone: [646-619-1811]; Email: freya.smale@terrapinn.com
  
132.Cancer and Autoimmunity 2016 — Emerging Target Therapies in Cancer & Autoimmunity
 Dates 21 Apr 2016 → 25 Apr 2016
[ID=738350] Go to top of page
 LocationVaradero, Cuba
 Abstract The four-day event will bring together basic scientists, medicinal chemists, pharmacologists, biotechnologists, clinical investigators, and other allied professionals from around the world, interested in the fields of disease pathogenesis and new targeted therapies development for Cancer and for Autoimmune Disorders. The meeting will be an excellent opportunity to expose the translational nature of modern biomedical and pharmaceutical research. One of the key objectives of the 2016 Symposium will be to arm delegates with the necessary tools that will enable them to make a difference, implement and take actions at all levels, in global fight against cancer or autoimmunity diseases.
 Topics Molecular oncology; Tumor immunology; Cancer Immunotherapy, Clinical trials; Mechanisms of autoimmune-related diseases; Regulatory T cells and autoimmunity; Pharmacological strategies for treatment
 Weblink http://biomed.cigb.edu.cu/can16/can16default.aspx
 Contact Jesus Benitez; Email: biomed@cigb.edu.cu
 Related subject(s) Oncology
  
133.Adverse Drug Reactions, Drug Interactions and Pharmacovigilance Course
 Dates 09 May 2016 → 13 May 2016
[ID=722708] Go to top of page
 LocationOxford, United Kingdom
 Weblink https://www.conted.ox.ac.uk/courses/details.php?id=B900-31
 Contact Course Administrator; Phone: [01865 286955]; Email: expther@conted.ox.ac.uk
  
134.ECI — Vaccine Technology VI
 Dates 12 Jun 2016 → 17 Jun 2016
[ID=738469] Go to top of page
 LocationCetraro, Calabria, Italy
 Abstract This conference series addresses technical and scientific issues in the development and manufacturing of vaccines. It will also discuss broader issues related to vaccine development and access that will be of interest to institutional and academic participants. Emphasis will be particularly placed on emerging diseases and developing world.
 Topics Break through developments in vaccinology •Issues and case studies in process development •Formulating and delivering vaccines •Vaccine characterization/analytics •Therapeutic vaccines •Case studies •New challenges, new technologies in vaccine development. •One world, one health
 Weblink http://www.engconf.org/conferences/biotechnology/vaccine-technology-vi/
 Contact Arlene Conway; Phone: [212 514 6760]; Email: info@rngconfintl.org
  
135.Vaccine Technology VI
 Dates 12 Jun 2016 → 17 Jun 2016
[ID=721600] Go to top of page
 LocationAlbufeira, Portugal
 Topics In line with previous years, session topics will focus on all aspects of vaccine technology. This will include: •early antigen discovery and design •process development •analytics •clinical trials •commercialization.
 Weblink http://www.engconf.org/conferences/biotechnology/vaccine-technology-vi/
 Contact ARLENE CONWAY; Phone: [2125146760]; Email: info@engconfintl.org
  
136.6th RSC / SCI symposium on GPCRs in Medicinal Chemistry
 Dates 13 Jun 2016 → 15 Jun 2016
[ID=740279] Go to top of page
 LocationVerona, Italy
 Abstract The key role of G-protein coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Aptuit, Italy will support the sixth meeting in this series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.
 Weblink http://www.maggichurchouseevents.co.uk/bmcs
 Related subject(s) Biochemistry and Medicinal Chemistry, Toxicology
  
137.Asia-Pacific Pharma Congress
 Dates 14 Jul 2016 → 16 Jul 2016
[ID=726891] Go to top of page
 LocationKuala Lumpur, Malaysia
 Abstract Asia Pharma-2016 is supported with related journals and their editorial board members which provide a chance of meeting them, along with experts in Medicine, Pharmacological sciences and Pharmaceutical sciences.Asia Pharma-2016 will be a great event where experts from universities, top Pharmaceutical industries, research centers and from the societies and association related to Pharmaceuticals. So, all are whole heartedly invited to be a part of this conference.
 Topics IPR and Regulatory Affairs, Pharmacognosy, Pharmaceutics, Nanotechnology, Industrial Pharmacy, Pharmacology, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry, Hospital and Clinical Pharmacy.
 Weblink http://asiapacific.pharmaceuticalconferences.com/
 Contact Robert Brown; Phone: [1-650-268-9744]; Email: asiapharma@pharmaceuticalconferences.com
  

Last updated: 02 September 2015